{ "company": "Thermo Fisher Scientific", "ticker": "TMO", "period": { "from": "2026-03-13", "to": "2026-04-12", "days": 30 }, "sentiment_breakdown": { "positive": 94, "negative": 46, "neutral": 61 }, "synthesis": { "executive_summary": "Sentiment analysis for Thermo Fisher Scientific (TMO) from 2026-03-13 to 2026-04-12. Analyzed 201 items across FDA and news sources.", "key_findings": [], "overall_sentiment": "neutral" }, "top_positive": [ { "title": "Immunohistochemistry Market Led by Diagnostics Segment with 60%+ Share; Market Projected to Reach USD 4.42 billion by 2031, Mordor Intelligence Reports", "date": "2026-04-10", "source": "news", "score": 1.0 }, { "title": "Active Pharmaceutical Ingredients CDMO Market Research and Global Forecast Report 2025-2032: Exploring Service Models, Analytical Services, Process Developments, and More", "date": "2026-04-09", "source": "news", "score": 1.0 }, { "title": "Biopharmaceuticals Contract Manufacturing Market Global Forecast Report 2026-2032: A Cornerstone for Operational Efficiency, Agility, and Strategic Focus Amid a Rapidly Evolving Therapeutic Landscape", "date": "2026-04-08", "source": "news", "score": 1.0 }, { "title": "Pharmaceutical Excipient Market - Global Forecast 2026-2032: Growth Driven by Innovation, Compliance Needs, and Digital Procurement with Emphasis on Supply Resilience, and Sustainability,", "date": "2026-04-08", "source": "news", "score": 1.0 }, { "title": "Global In Vitro Fertilization Market to Reach USD 1,650 Million by 2029 | MarketsandMarkets™", "date": "2026-04-06", "source": "news", "score": 0.984 }, { "title": "Global Metabolomics Market Poised for Strong Growth as Advancements in Precision Medicine and Biomarker Discovery Accelerate Adoption: Verified Market Research®", "date": "2026-04-10", "source": "news", "score": 0.951 }, { "title": "$1.05 Bn Biopharmaceutical CXO Markets - Global Forecast Report 2026-2032: How Leading Pharmas Such as Pfizer, Roche, Novartis, Sanofi, and AstraZeneca Navigate the Evolving Dynamics", "date": "2026-04-09", "source": "news", "score": 0.943 }, { "title": "Murphy praises Ulster 'grit' in win over Ospreys", "date": "2026-04-05", "source": "news", "score": 0.94 }, { "title": "Murphy praises Ulster 'grit' in win over Ospreys", "date": "2026-04-05", "source": "news", "score": 0.94 }, { "title": "Wakefield beat Castleford to keep pace with leaders", "date": "2026-04-05", "source": "news", "score": 0.915 } ], "top_negative": [ { "title": "DNA damage burden causes selective CUX2 neuron loss in neuroinflammation", "date": "2026-04-01", "source": "news", "score": -1.0 }, { "title": "Global Noninvasive Cancer Diagnostics Market to Reach $165.2 Billion by 2030 as Liquid Biopsy, AI-Enabled Screening and Multi-Cancer Detection Tests Transform Oncology", "date": "2026-04-09", "source": "news", "score": -0.823 }, { "title": "Charged molecular glue discovery enabled by targeted degron display", "date": "2026-04-06", "source": "news", "score": -0.823 }, { "title": "Anti-cancer effect of a novel photodynamic therapy using glucose-linked chlorin e6 conjugated trastuzumab for HER2-positive gastrointestinal cancers", "date": "2026-04-03", "source": "news", "score": -0.807 }, { "title": "Deconstruction of a spino-brain–spinal cord circuit that drives chronic pain", "date": "2026-04-01", "source": "news", "score": -0.765 }, { "title": "Association between chronic stress and the epigenome: Exploration of psychological and biological stress", "date": "2026-04-06", "source": "news", "score": -0.751 }, { "title": "Specificity and recognition of the ADP-ribosyl-ubiquitin modification in the DNA damage response", "date": "2026-04-02", "source": "news", "score": -0.751 }, { "title": "Combined Nutritional and Exercise Interventions for Cachexia in Chronic Diseases: A Systematic Review and Meta-analysis Limited to Cancer Cachexia.", "date": "2026-04-12", "source": "pubmed", "score": -0.743 }, { "title": "Discovery of a potent anti-Zika virus benzamide series targeting the viral protein NS4B", "date": "2026-04-03", "source": "news", "score": -0.735 }, { "title": "Impact of tumor location on the efficacy of concurrent chemoradiotherapy for locally advanced non-small cell lung cancer.", "date": "2026 Apr 9", "source": "pubmed", "score": -0.718 } ], "raw_data": { "total_items": 201, "items": [ { "source": "alpha_vantage", "title": "Is Thermo Fisher Scientific (TMO) Pricing Look Stretched After Recent Share Price Rebound", "url": "https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-tmo/thermo-fisher-scientific/news/is-thermo-fisher-scientific-tmo-pricing-look-stretched-after", "date": "2026-04-12", "summary": "This article analyzes Thermo Fisher Scientific's (TMO) stock valuation after recent share price movements. Using a Discounted Cash Flow (DCF) model, the stock appears overvalued by 62.9%, with an intrinsic value of $304.61 compared to its current price of $496. However, its P/E ratio of 27.5x is below the Life Sciences industry average, suggesting it could be considered \"about right\" based on that metric, and conflicting Narratives on Simply Wall St offer various fair value estimates.", "sentiment_score": 0.032477, "sentiment_label": "Neutral", "relevance_score": 0.328849, "sentiment": { "label": "positive", "score": 0.296, "confidence": 0.3 } }, { "source": "alpha_vantage", "title": "Does Tempus AI’s (TEM) Deeper Gilead Tie Mark a Shift in Its Platform Strategy?", "url": "https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-tem/tempus-ai/news/does-tempus-ais-tem-deeper-gilead-tie-mark-a-shift-in-its-pl", "date": "2026-04-11", "summary": "Tempus AI has expanded its collaboration with Gilead Sciences, granting Gilead enterprise-wide access to its AI-driven Lens platform and oncology datasets. This integration aims to embed Tempus' technology into Gilead's oncology R&D, influencing trial design, biomarker strategy, and real-world evidence generation. While this deepens pharma integration, the article highlights the ongoing tension between Tempus' strong forecast revenue growth and continued losses, emphasizing the need for improvin", "sentiment_score": 0.100422, "sentiment_label": "Neutral", "relevance_score": 0.729357, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Wallace Advisory Group Reduces Stake in Thermo Fisher Scientific", "url": "https://nationaltoday.com/us/ny/new-york/news/2026/04/11/wallace-advisory-group-reduces-stake-in-thermo-fisher-scientific/", "date": "2026-04-11", "summary": "Wallace Advisory Group LLC decreased its stake in Thermo Fisher Scientific Inc. (NYSE:TMO) by 74.0% during the fourth quarter of 2025, selling 1,717 shares. The institutional investor now holds 602 shares valued at $349,000. This move suggests a potential shift in Wallace Advisory Group's investment strategy or outlook on the medical research sector, reflecting broader trends in financial markets as firms adjust portfolios.", "sentiment_score": -0.131988, "sentiment_label": "Neutral", "relevance_score": 1.0, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Thermo Fisher expands global biobank leadership through collaboration with PRECISE-SG100K Singapore", "url": "https://www.biospectrumasia.com/news/41/27485/thermo-fisher-expands-global-biobank-leadership-through-collaboration-with-precise-sg100k-singapore.html", "date": "2026-04-11", "summary": "Thermo Fisher Scientific has announced a strategic collaboration with Precision Health Research, Singapore (PRECISE) to advance the PRECISE-SG100K study, a major population-scale biobank initiative. This partnership aims to leverage proteomics and AI-driven analytics to enhance disease detection, prevention, and personalized care. The collaboration will integrate Thermo Fisher's Olink® Proximity Extension Assay (PEA) platforms with Orbitrap Astral mass spectrometry, alongside Seer’s Proteograph®", "sentiment_score": 0.445068, "sentiment_label": "Bullish", "relevance_score": 1.0, "sentiment": { "label": "positive", "score": 0.103, "confidence": 0.1 } }, { "source": "alpha_vantage", "title": "Avantor Inc stock (US05352A1007): Is its lab supply dominance strong enough for U.S. investor upside", "url": "https://www.ad-hoc-news.de/boerse/ueberblick/avantor-inc-stock-us05352a1007-is-its-lab-supply-dominance-strong/69120630", "date": "2026-04-10", "summary": "Avantor Inc. (AVTR) provides critical products and services to the life sciences industry, enabling research and biopharma in the U.S. The company operates an asset-light model, supplying essential lab materials and services, making it a \"pick-and-shovel\" play for investors seeking exposure to the booming American biotech sector without direct drug development risks. While benefiting from strong R&D spending and U.S. market reach, investors should monitor risks like R&D spending slowdowns and su", "sentiment_score": 0.109078, "sentiment_label": "Neutral", "relevance_score": 0.626592, "sentiment": { "label": "positive", "score": 0.625, "confidence": 0.62 } }, { "source": "alpha_vantage", "title": "Illumina Inc stock (US4523271090): Is its genomics dominance strong enough to unlock new upside?", "url": "https://www.ad-hoc-news.de/boerse/ueberblick/illumina-inc-stock-us4523271090-is-its-genomics-dominance-strong-enough/69120781", "date": "2026-04-10", "summary": "Illumina Inc. is a dominant provider of DNA sequencing technology, crucial for biotech and personalized medicine, positioning its stock as a key investment for U.S. investors in the biotech sector. Its business model relies on high-margin consumables, strategic scalability, and underpinning FDA-approved tests and NIH-funded projects. Despite competitive and regulatory risks, the company's continuous innovation and alignment with precision medicine trends suggest potential for continued growth.", "sentiment_score": 0.137327, "sentiment_label": "Neutral", "relevance_score": 0.564074, "sentiment": { "label": "positive", "score": 0.625, "confidence": 0.62 } }, { "source": "alpha_vantage", "title": "Thermo Fisher Sci. stock (US8835561023): Is its life sciences dominance strong enough to unlock new upside?", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/thermo-fisher-sci-stock-us8835561023-is-its-life-sciences-dominance/69119588", "date": "2026-04-10", "summary": "Thermo Fisher Scientific (US8835561023) is positioned as a leader in life sciences tools, diagnostics, and biopharma services, making it a crucial stock for investors tracking biotech and healthcare trends, particularly in the U.S. Its integrated business model, which spans four segments, focuses on robust recurring revenue from consumables and high-margin services, enabling it to capitalize on industry tailwinds like precision medicine and gene therapy. While macroeconomic slowdowns and supply ", "sentiment_score": 0.038578, "sentiment_label": "Neutral", "relevance_score": 0.306699, "sentiment": { "label": "positive", "score": 0.625, "confidence": 0.62 } }, { "source": "alpha_vantage", "title": "Thermo Fisher Sci. stock (US8835561023): Is its life sciences dominance strong enough to unlock new upside?", "url": "https://www.ad-hoc-news.de/boerse/ueberblick/thermo-fisher-sci-stock-us8835561023-is-its-life-sciences-dominance/69119588", "date": "2026-04-10", "summary": "This article examines Thermo Fisher Scientific (US8835561023), a Nasdaq-listed giant in the life sciences sector, and its potential for continued growth. It highlights the company's core business model, which integrates various segments to support the entire research-to-commercialization pipeline, and its strong presence in the U.S. market. The piece also discusses analyst views, potential risks, and future catalysts relevant to U.S. investors, emphasizing its role in healthcare innovation and i", "sentiment_score": 0.043815, "sentiment_label": "Neutral", "relevance_score": 0.349644, "sentiment": { "label": "positive", "score": 0.625, "confidence": 0.62 } }, { "source": "alpha_vantage", "title": "Does Charles River’s NSG BioLabs Tie-Up Reshape the Bull Case For Charles River Laboratories (CRL)?", "url": "https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-crl/charles-river-laboratories-international/news/does-charles-rivers-nsg-biolabs-tie-up-reshape-the-bull-case", "date": "2026-04-10", "summary": "Charles River Laboratories (CRL) recently signed a Memorandum of Understanding with NSG BioLabs, expanding its presence in the Asia-Pacific region and enhancing its role as an end-to-end partner for emerging biotech companies. This collaboration, while not impacting near-term profitability, supports Charles River's long-term strategy of embedding itself in new modalities like oncology and cell and gene therapy. Investors are advised to consider this expansion in the context of Charles River's ex", "sentiment_score": 0.013113, "sentiment_label": "Neutral", "relevance_score": 0.633592, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Seer Joins Thermo Fisher Tools In Large-Scale Proteomics Effort", "url": "https://www.sahmcapital.com/news/content/seer-joins-thermo-fisher-tools-in-large-scale-proteomics-effort-2026-04-09", "date": "2026-04-10", "summary": "Seer Inc. announced that its Proteograph Product Suite will be used in the PRECISE-SG100K study, a large-scale population health initiative in Singapore, to profile the plasma proteome of 10,000 participants. This collaboration integrates Seer's platform with Thermo Fisher Scientific's Olink Reveal and Orbitrap Astral mass spectrometers to deepen proteomic insights within a diverse Asian population. The initiative aims to support precision health research, disease prevention, and therapeutic dis", "sentiment_score": 0.241046, "sentiment_label": "Somewhat-Bullish", "relevance_score": 0.862192, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Rx Rundown: Gilead Sciences, Jeito Capital, Neurocrine Biosciences and more", "url": "https://www.mmm-online.com/news/rx-rundown-gilead-sciences-jeito-capital-neurocrine-biosciences-and-more/", "date": "2026-04-10", "summary": "This article provides a \"Rx Rundown\" summarizing significant medical marketing news, dealmaking, and industry chatter. Key highlights include major acquisitions by Gilead Sciences and Neurocrine Biosciences, various funding rounds for biotech firms, FDA approvals and warnings, and notable layoffs in the pharmaceutical sector. Additionally, it covers industry news from companies like Novo Nordisk, Amgen, and Novartis, along with updates on partnerships and research initiatives.", "sentiment_score": 0.117717, "sentiment_label": "Neutral", "relevance_score": 0.558844, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Flow Cytometry Market is experiencing boost at an infinite speed", "url": "https://www.openpr.com/news/4464267/flow-cytometry-market-is-experiencing-boost-at-an-infinite-speed", "date": "2026-04-10", "summary": "The Flow Cytometry Market is projected to reach US$ 9.82 Billion by 2031, with a CAGR of 9.0% from 2025-2031, driven by advancements in technology, increasing prevalence of diseases like cancer, and growing demand for personalized medicine. Key drivers include its vital role in immunology, oncology, stem cell research, and drug discovery. North America currently dominates the market, while Asia-Pacific is expected to show the fastest growth, presenting significant opportunities for market player", "sentiment_score": 0.70225, "sentiment_label": "Bullish", "relevance_score": 0.90347, "sentiment": { "label": "positive", "score": 0.402, "confidence": 0.4 } }, { "source": "alpha_vantage", "title": "Thermo Fisher Partnership With PRECISE Puts Proteomics At Core Of TMO Story", "url": "https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-tmo/thermo-fisher-scientific/news/thermo-fisher-partnership-with-precise-puts-proteomics-at-co", "date": "2026-04-10", "summary": "Thermo Fisher Scientific has partnered with Precision Health Research, Singapore (PRECISE) for a large-scale proteomics biobank initiative, the PRECISE-SG100K project. This collaboration will utilize Thermo Fisher's platforms, like Olink PEA and Orbitrap Astral mass spectrometry, within one of Asia's largest longitudinal population health studies. For investors, this signifies Thermo Fisher's deeper integration into global research infrastructure and its commitment to providing high-end tools fo", "sentiment_score": 0.416614, "sentiment_label": "Bullish", "relevance_score": 1.0, "sentiment": { "label": "positive", "score": 0.2, "confidence": 0.2 } }, { "source": "alpha_vantage", "title": "Thermo Fisher Shares Could See Gains After Teaming Up With PRECISE", "url": "https://www.bitget.com/news/detail/12560605356458", "date": "2026-04-10", "summary": "Thermo Fisher Scientific (TMO) has partnered with PRECISE for the SG100K initiative, aiming to advance proteomics research for disease understanding and personalized healthcare. Despite an initial dip in share price after the announcement, Thermo Fisher's extensive involvement in large biobank projects globally, coupled with new product launches and strong earnings, positions it for potential future growth in the expanding biobanking market. The collaboration utilizes advanced proteomic technolo", "sentiment_score": 0.009227, "sentiment_label": "Neutral", "relevance_score": 0.304607, "sentiment": { "label": "positive", "score": 0.557, "confidence": 0.56 } }, { "source": "alpha_vantage", "title": "Niagen Bioscience Establishes First-Ever USP Monograph for Patented Nicotinamide Riboside Chloride", "url": "https://nationaltoday.com/us/ca/los-angeles/news/2026/04/09/niagen-bioscience-establishes-first-ever-usp-monograph-for-patented-nicotinamide-riboside-chloride/", "date": "2026-04-09", "summary": "Niagen Bioscience has achieved a significant milestone by establishing the first-ever USP monograph for its patented Nicotinamide Riboside Chloride (NRCl), used in Niagen supplements. This sets a new quality standard for NR, NMN, and NAD+ compounds, reinforcing the company's leadership in NAD+ science. The monograph provides a clear quality benchmark for the NAD+ supplement industry, benefiting consumers with consistent and high-quality products.", "sentiment_score": 0.262363, "sentiment_label": "Somewhat-Bullish", "relevance_score": 0.742459, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Seer, Inc. and Precision Health Research, Singapore Sign Collaboration to Provide Deep, Unbiased Proteomics on 10,000 Precise Sg100k Samples", "url": "https://www.marketscreener.com/news/seer-inc-and-precision-health-research-singapore-sign-collaboration-to-provide-deep-unbiased-pro-ce7e50d8db80f527", "date": "2026-04-09", "summary": "Seer, Inc. announced a collaboration with Precision Health Research, Singapore (PRECISE-SG100K) to use its Proteograph Product Suite for deep proteomic profiling of 10,000 plasma samples from the PRECISE-SG100K cohort. This will integrate with existing genomic and health data to create one of the world's most comprehensive multi-omic datasets for advancing precision health, disease prevention, and therapeutic discovery. The collaboration aims to link genetic variation with protein networks and c", "sentiment_score": 0.222521, "sentiment_label": "Somewhat-Bullish", "relevance_score": 0.606473, "sentiment": { "label": "neutral", "score": -0.026, "confidence": 0.03 } }, { "source": "alpha_vantage", "title": "Thermo Fisher Scientific Expands Global Biobank Leadership", "url": "https://nationaltoday.com/us/ma/waltham/news/2026/04/09/thermo-fisher-scientific-expands-global-biobank-leadership/", "date": "2026-04-09", "summary": "Thermo Fisher Scientific has announced a strategic collaboration with Precision Health Research, Singapore (PRECISE) to advance the PRECISE-SG100K project. This initiative aims to perform population-scale proteomics research by analyzing protein profiles from 100,000 Singaporean individuals, utilizing Thermo Fisher's advanced mass spectrometry technology. The goal is to gain deeper insights into diseases and health, potentially leading to new biomarkers and therapeutic targets.", "sentiment_score": 0.406353, "sentiment_label": "Bullish", "relevance_score": 0.998504, "sentiment": { "label": "positive", "score": 0.103, "confidence": 0.1 } }, { "source": "alpha_vantage", "title": "Thermo Fisher Scientific Expands Global Biobank Leadership Through Strategic Collaboration with PREC", "url": "https://www.pharmiweb.com/press-release/2026-04-09/thermo-fisher-scientific-expands-global-biobank-leadership-through-strategic-collaboration-with-prec", "date": "2026-04-09", "summary": "Thermo Fisher Scientific Inc. has announced a strategic collaboration with Precision Health Research, Singapore (PRECISE) to advance the PRECISE-SG100K study, one of the region's largest population-scale biobank initiatives. This partnership aims to leverage proteomics, multi-omic platforms, and AI-driven analytics to gain insights into disease biology for earlier detection, prevention, and personalized care. The collaboration will utilize Thermo Fisher's Olink® Proximity Extension Assay (PEA) p", "sentiment_score": 0.414393, "sentiment_label": "Bullish", "relevance_score": 1.0, "sentiment": { "label": "positive", "score": 0.103, "confidence": 0.1 } }, { "source": "alpha_vantage", "title": "How Investors May Respond To Thermo Fisher Scientific (TMO) Expanding Its Cell Therapy And Biologics Platforms", "url": "https://www.sahmcapital.com/news/content/how-investors-may-respond-to-thermo-fisher-scientific-tmo-expanding-its-cell-therapy-and-biologics-platforms-2026-04-08", "date": "2026-04-09", "summary": "Thermo Fisher Scientific recently expanded its cell therapy and biologics platforms and unveiled new technologies, reinforcing its role in biomanufacturing and advanced research. These moves, particularly the CTS Compleo cell therapy system, are expected to deepen the company's position in high-value markets. While analysts project significant revenue and earnings growth with a substantial upside to its current price, investors are advised to also consider potential risks such as tariff exposure", "sentiment_score": 0.259947, "sentiment_label": "Somewhat-Bullish", "relevance_score": 1.0, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Thermo Fisher Scientific Partners PRECISE To Advance Singapore’s Landmark SG100K Biobank Study", "url": "https://biopharmaapac.com/news/89/7806/thermo-fisher-scientific-partners-precise-to-advance-singapores-landmark-sg100k-biobank-study.html", "date": "2026-04-09", "summary": "Thermo Fisher Scientific has announced a strategic collaboration with Precision Health Research, Singapore (PRECISE) to further the SG100K biobank study. This partnership aims to integrate multi-omics and AI-driven analytics, utilizing Thermo Fisher's Olink® Proximity Extension Assay platforms and Orbitrap Astral mass spectrometry system to accelerate early disease detection, biomarker discovery, and precision medicine. The collaboration highlights the growing trend of national population studie", "sentiment_score": 0.487981, "sentiment_label": "Bullish", "relevance_score": 1.0, "sentiment": { "label": "positive", "score": 0.077, "confidence": 0.08 } }, { "source": "alpha_vantage", "title": "DNA Sequencing Market Leading Players Analysis - Abbott", "url": "https://www.openpr.com/news/4462560/dna-sequencing-market-leading-players-analysis-abbott", "date": "2026-04-09", "summary": "The global DNA Sequencing Market is experiencing significant growth, projected to register a 20% CAGR from 2025 to 2031, driven by technological advancements, expanding clinical applications, and increased investment in genomics research. Key players include Abbott Laboratories, Agilent Technologies, and Danaher Corporation, with North America dominating and Asia-Pacific emerging as a high-growth region. The market is fueled by applications in clinical diagnostics, agriculture, environmental sci", "sentiment_score": 0.32096, "sentiment_label": "Somewhat-Bullish", "relevance_score": 0.855201, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Thermo Fisher Scientific Expands Global Biobank Leadership Through Strategic Collaboration with PRECISE-SG100K Singapore to Advance Population-Scale Proteomics", "url": "https://www.businesswire.com/news/home/20260409180970/en/Thermo-Fisher-Scientific-Expands-Global-Biobank-Leadership-Through-Strategic-Collaboration-with-PRECISE-SG100K-Singapore-to-Advance-Population-Scale-Proteomics", "date": "2026-04-09", "summary": "Thermo Fisher Scientific has partnered with Precision Health Research, Singapore (PRECISE) to advance the PRECISE-SG100K study, one of the region's largest population-scale biobank initiatives. This collaboration aims to leverage proteomics and AI-driven analytics to gain insights into disease biology for early detection, prevention, and personalized care. Thermo Fisher will deploy its Olink® Proximity Extension Assay platforms alongside the Orbitrap Astral mass spectrometry system to support th", "sentiment_score": 0.417492, "sentiment_label": "Bullish", "relevance_score": 1.0, "sentiment": { "label": "positive", "score": 0.103, "confidence": 0.1 } }, { "source": "alpha_vantage", "title": "Singapore health study taps Thermo Fisher for disease-tracking proteins", "url": "https://www.stocktitan.net/news/TMO/thermo-fisher-scientific-expands-global-biobank-leadership-through-5mhzenfrsfjn.html", "date": "2026-04-09", "summary": "Thermo Fisher Scientific has announced a strategic collaboration with Singapore's Precision Health Research (PRECISE) to advance the PRECISE-SG100K study. This partnership focuses on utilizing proteomics to understand disease biology for early detection, prevention, and personalized care within one of the region's most ambitious population-scale biobank initiatives. The study will integrate Thermo Fisher's Olink® Proximity Extension Assay (PEA) platforms with the Orbitrap Astral mass spectrometr", "sentiment_score": 0.463643, "sentiment_label": "Bullish", "relevance_score": 0.955514, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Merck & Co., Inc. $MRK Shares Sold by Addenda Capital Inc.", "url": "https://www.marketbeat.com/instant-alerts/filing-merck-co-inc-mrk-shares-sold-by-addenda-capital-inc-2026-04-09/", "date": "2026-04-09", "summary": "Addenda Capital Inc. reduced its stake in Merck & Co., Inc. by 9.9% in Q4, selling 9,595 shares and concluding the period with 87,800 shares valued at approximately $9.32 million. Merck surpassed Q4 earnings expectations with an EPS of $2.04 and revenue of $16.4 billion, also providing a positive FY2026 EPS guidance. The company launched a tender offer for Terns Pharmaceuticals to enhance its oncology pipeline, although the offer price was adjusted after trial data review.", "sentiment_score": 0.310901, "sentiment_label": "Somewhat-Bullish", "relevance_score": 0.629639, "sentiment": { "label": "positive", "score": 0.296, "confidence": 0.3 } }, { "source": "alpha_vantage", "title": "TMO Forecast, Price Target & Analyst Ratings | THERMO FISHER SCIENTIFIC INC (NYSE:TMO)", "url": "https://www.chartmill.com/stock/quote/TMO/analyst-ratings", "date": "2026-04-09", "summary": "THERMO FISHER SCIENTIFIC INC (TMO) currently trades at $496.11, with analysts setting an average price target of $670.05, suggesting a 35.06% upside. The company is expected to report Q1 2026 earnings on April 23, 2026, with estimated EPS of $5.29 and revenue of $10.952 billion. Analysts maintain a strong \"Buy\" consensus with 84% of 35 analysts recommending a buy.", "sentiment_score": 0.416039, "sentiment_label": "Bullish", "relevance_score": 1.0, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "BLFS Stock Price, Quote & Chart | BIOLIFE SOLUTIONS INC (NASDAQ:BLFS)", "url": "https://www.chartmill.com/stock/quote/BLFS/profile", "date": "2026-04-08", "summary": "This article provides detailed stock information for BioLife Solutions Inc. (NASDAQ: BLFS), including its current stock price, performance metrics, key statistics, technical and fundamental analysis ratings from ChartMill, and insights into its latest earnings report and analyst forecasts. The company specializes in biopreservation tools for cells and tissues.", "sentiment_score": 0.12878, "sentiment_label": "Neutral", "relevance_score": 0.627943, "sentiment": { "label": "positive", "score": 0.347, "confidence": 0.35 } }, { "source": "alpha_vantage", "title": "Thermo Fisher Scientific stock: Steady growth amid biotech shifts – what investors need to know", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/thermo-fisher-scientific-stock-steady-growth-amid-biotech-shifts-what/69107374", "date": "2026-04-08", "summary": "Thermo Fisher Scientific is positioned for steady growth in the life sciences sector, driven by its integrated approach to drug development and research, and key product launches. The company's strong financial performance, consistent revenue growth, and strategic acquisitions allow it to maintain a competitive edge. Investors are advised to consider its long-term potential, while monitoring macroeconomic factors and upcoming earnings reports.", "sentiment_score": 0.508639, "sentiment_label": "Bullish", "relevance_score": 1.0, "sentiment": { "label": "positive", "score": 0.382, "confidence": 0.38 } }, { "source": "alpha_vantage", "title": "Thermo Fisher Scientific Inc. stock rises Wednesday, outperforms market", "url": "https://www.marketwatch.com/data-news/thermo-fisher-scientific-inc-stock-rises-wednesday-outperforms-market-0f75ffea-137ffa903307", "date": "2026-04-08", "summary": "Shares of Thermo Fisher Scientific Inc. (TMO) increased by 2.85% to reach $503.46 on Wednesday, outperforming the broader market. This rise occurred during a favorable trading session where both the S&P 500 Index and the Dow Jones Industrial Average also saw significant gains. This marks the second consecutive day of gains for the stock.", "sentiment_score": 0.438147, "sentiment_label": "Bullish", "relevance_score": 1.0, "sentiment": { "label": "positive", "score": 0.2, "confidence": 0.2 } }, { "source": "alpha_vantage", "title": "Biotechnology Reagents and Kits Market Set to Witness Rapid Growth Through 2033 | Thermo Fisher Scientific, Inc., QIAGEN, New England Biolabs", "url": "https://www.openpr.com/news/4460206/biotechnology-reagents-and-kits-market-set-to-witness-rapid", "date": "2026-04-08", "summary": "The Biotechnology Reagents and Kits Market is projected to grow from USD 828.0 Mn in 2025 to USD 1,774.0 Mn in 2032, exhibiting an 11.5% CAGR. This market, driven by innovation and investment, is undergoing significant segmentation by kit type, technology, tested parameters, purpose, and end-use across various regions. The report provides a deep dive into market structure, competitive landscape, and strategic insights for decision-makers.", "sentiment_score": 0.349952, "sentiment_label": "Somewhat-Bullish", "relevance_score": 0.926246, "sentiment": { "label": "positive", "score": 0.382, "confidence": 0.38 } }, { "source": "alpha_vantage", "title": "Waters Corp stock: What investors need to know in today's market", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/waters-corp-stock-what-investors-need-to-know-in-today-s-market/69104060", "date": "2026-04-08", "summary": "Waters Corp, a leader in analytical instruments like chromatography and mass spectrometry, offers stability for investors due to its essential role in drug discovery, material science, and environmental testing. The company's diversified portfolio, global footprint, and recurring revenue model from consumables provide a competitive edge. While facing risks like supply chain disruptions, its strong market position in critical industries makes it an attractive long-term investment, particularly wi", "sentiment_score": 0.111809, "sentiment_label": "Neutral", "relevance_score": 0.614212, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "IQVIA.ai Launch With Nvidia Puts AI At Core Of Pharma Ties", "url": "https://www.sahmcapital.com/news/content/iqviaai-launch-with-nvidia-puts-ai-at-core-of-pharma-ties-2026-04-07", "date": "2026-04-08", "summary": "IQVIA Holdings has launched IQVIA.ai, a new AI platform developed with Nvidia, aimed at integrating healthcare-grade AI, data, and compliance for life sciences clients. The platform is already seeing adoption among several top global pharmaceutical companies, positioning IQVIA to deepen client relationships and differentiate itself in a competitive market. Investors are advised to monitor the platform's impact on contract wins, client spending, and the company's financial performance amidst pote", "sentiment_score": 0.129872, "sentiment_label": "Neutral", "relevance_score": 0.617926, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "How Investors May Respond To Thermo Fisher Scientific (TMO) Expanding Its Cell Therapy And Biologics Platforms", "url": "https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-tmo/thermo-fisher-scientific/news/how-investors-may-respond-to-thermo-fisher-scientific-tmo-ex-1/amp", "date": "2026-04-08", "summary": "Thermo Fisher Scientific recently expanded its cell therapy and biologics platforms with new product launches and collaborations, including the CTS Compleo cell therapy system. These strategic moves aim to strengthen its role as an integrated partner in biopharma and cell/gene therapy. While these developments could boost Thermo Fisher's growth profile, investors should also consider potential risks such as tariffs and exposure to the Chinese market.", "sentiment_score": 0.316864, "sentiment_label": "Somewhat-Bullish", "relevance_score": 1.0, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Lobbying Update: $21,000 of THERMO FISHER SCIENTIFIC INC lobbying was just disclosed", "url": "https://www.quiverquant.com/news/Lobbying+Update:+$21,000+of+THERMO+FISHER+SCIENTIFIC+INC+lobbying+was+just+disclosed", "date": "2026-04-07", "summary": "THERMO FISHER SCIENTIFIC INC (TMO) recently disclosed $21,000 in lobbying expenditures for Q1 2026, focusing on promoting FDA-cleared preeclampsia biomarker testing in Medicaid. The article also details congressional and insider trading activity, institutional investor movements, and analyst ratings and price targets for TMO.", "sentiment_score": 0.040246, "sentiment_label": "Neutral", "relevance_score": 0.343285, "sentiment": { "label": "negative", "score": -0.153, "confidence": 0.15 } }, { "source": "alpha_vantage", "title": "How Investors May Respond To Thermo Fisher Scientific (TMO) Expanding Its Cell Therapy And Biologics Platforms", "url": "https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-tmo/thermo-fisher-scientific/news/how-investors-may-respond-to-thermo-fisher-scientific-tmo-ex-1", "date": "2026-04-07", "summary": "Thermo Fisher Scientific recently expanded its cell therapy and biologics platforms, including the new CTS Compleo cell therapy system, and entered a collaboration with SHL Medical. These initiatives aim to strengthen its role in high-value biomanufacturing and advanced research. While these moves are seen as positive for the company's growth profile, investors should also consider potential risks such as tariffs and China exposure.", "sentiment_score": 0.343444, "sentiment_label": "Somewhat-Bullish", "relevance_score": 0.997871, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Azenta names Trey Martin president of Multiomics business By Investing.com", "url": "https://uk.investing.com/news/company-news/azenta-names-trey-martin-president-of-multiomics-business-93CH-4596209", "date": "2026-04-07", "summary": "Azenta, Inc. has appointed Trey Martin as President of its Multiomics business, effective April 6, 2026. Martin, previously CEO of Maravai Life Sciences and holding senior roles at Danaher Corporation, brings over 30 years of experience in life sciences and genomics platforms. This leadership change follows a period of stock volatility for Azenta, despite recent positive developments like an acquisition and strategic partnerships.", "sentiment_score": -0.137203, "sentiment_label": "Neutral", "relevance_score": 0.643828, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "How Bio-Techne's Spatial Biology COMET Expansion (TECH) Has Changed Its Investment Story", "url": "https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-tech/bio-techne/news/how-bio-technes-spatial-biology-comet-expansion-tech-has-cha", "date": "2026-04-07", "summary": "Bio-Techne recently expanded its COMET spatial biology portfolio with new SPYRE Focus Panels, SPYRE Amplification Kits, and upgraded HORIZON image analysis software. This move aims to enhance automated, modular tissue analysis and deepen the company's high-content spatial biology offerings. While this expansion reinforces Bio-Techne's long-term investment narrative focused on specialized tools, near-term challenges such as funding pressures in biotech and academia remain, making execution on hig", "sentiment_score": 0.106744, "sentiment_label": "Neutral", "relevance_score": 0.629328, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "How Investors May Respond To Thermo Fisher Scientific (TMO) Expanding Its Cell Therapy And Biologics Platforms", "url": "https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-tmo/thermo-fisher-scientific/news/como-podrian-reaccionar-los-inversores-ante-la-ampliacion-de-39", "date": "2026-04-07", "summary": "Thermo Fisher Scientific recently expanded its cell therapy and biologics platforms with new product launches and collaborations, including the CTS Compleo cell therapy system, CHOvantage biologics platform, Glacios 3 cryo-TEM, and a partnership with SHL Medical. These moves aim to strengthen Thermo Fisher's position in biomanufacturing and advanced research, potentially offsetting challenges in academic funding and analytical instruments. While analysts are optimistic about the revenue growth p", "sentiment_score": 0.41659, "sentiment_label": "Bullish", "relevance_score": 1.0, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "[ARS] THERMO FISHER SCIENTIFIC INC. SEC Filing", "url": "https://www.stocktitan.net/sec-filings/TMO/ars-thermo-fisher-scientific-inc-sec-filing-0f83318828ba.html", "date": "2026-04-07", "summary": "This article reports on an ARS SEC filing by Thermo Fisher Scientific Inc. (TMO) that was accepted on April 7, 2026, at 08:16 AM. The filing indicates a low impact and neutral sentiment. The article also provides an overview of TMO's stock data, rankings, and recent news and SEC filings.", "sentiment_score": 0.039817, "sentiment_label": "Neutral", "relevance_score": 0.333284, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Thermo Fisher Scientific appoints Somya Sugandha as VP HR, APMEA", "url": "https://www.hrkatha.com/people/movement/thermo-fisher-scientific-appoints-somya-sugandha-as-vp-hr-apmea/", "date": "2026-04-07", "summary": "Somya Sugandha has been appointed as Vice President, Human Resources for the APMEA region at Thermo Fisher Scientific. With over 25 years of experience from companies like Alstom, General Electric, and GE Vernova, Sugandha will be responsible for aligning people strategy, driving talent strategy, and enhancing organizational effectiveness. Her role will focus on fostering growth and cultural transformation within the diverse APMEA region.", "sentiment_score": 0.402634, "sentiment_label": "Bullish", "relevance_score": 1.0, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Evaluating Danaher (DHR) After Mixed Recent Returns And Conflicting Undervaluation Signals", "url": "https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-dhr/danaher/news/evaluating-danaher-dhr-after-mixed-recent-returns-and-confli", "date": "2026-04-07", "summary": "Danaher (DHR) is currently facing mixed investor sentiment due to a year of positive returns contrasted with recent declines over the last three months and month, alongside a 4.5% uptick in the past week. Despite having a projected fair value of $264.91, suggesting it's 27.5% undervalued, other analyses indicate a 13.2% undervaluation but with an expensive P/E ratio. The article advises investors to further analyze the company's prospects given these conflicting signals and potential risks.", "sentiment_score": -0.101167, "sentiment_label": "Neutral", "relevance_score": 0.649549, "sentiment": { "label": "negative", "score": -0.402, "confidence": 0.4 } }, { "source": "alpha_vantage", "title": "Somya Sugandha joins Thermo Fisher Scientific as Vice President – HR, APMEA", "url": "https://sea.peoplemattersglobal.com/news/appointments/somya-sugandha-joins-thermo-fisher-scientific-as-vice-president-hr-apmea-49133", "date": "2026-04-07", "summary": "Somya Sugandha has been appointed Vice President – Human Resources for the APMEA region at Thermo Fisher Scientific, bringing over 25 years of diverse HR experience. Previously, she spent nearly 14 years with Alstom, General Electric, and GE Vernova, where she significantly contributed to cultural transformation and employee experience. In her new role, she will align the people strategy with Thermo Fisher Scientific's mission to impact lives through science and innovation.", "sentiment_score": 0.413448, "sentiment_label": "Bullish", "relevance_score": 1.0, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "How Thermo Fisher’s Glacios 3 aims to broaden access to cryo-EM", "url": "https://www.rdworldonline.com/how-thermo-fishers-glacios-3-aims-to-broaden-access-to-cryo-em/", "date": "2026-04-07", "summary": "Thermo Fisher Scientific has introduced the Glacios 3 Cryo-TEM, a 200 kV cryo-electron microscope designed to overcome the historical challenges of bringing cryo-EM technology in-house for biotech and pharmaceutical companies. This new system, featuring a built-in environmental mitigation package (READY System) and AI-powered software, aims to simplify installation, reduce facility renovation needs, and make the technology more accessible and user-friendly. By streamlining operations and shorten", "sentiment_score": 0.04587, "sentiment_label": "Neutral", "relevance_score": 0.322576, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Encompass Health Corp Stock (EHC) Moved Up by 7.51% on Apr 6: What Signal Does It Send?", "url": "https://www.tradingkey.com/news/Market-Movers/261754526-market-movers-ehc-20260406", "date": "2026-04-06", "summary": "Encompass Health Corp (EHC) saw its stock rise by 7.51% on April 6, driven by a proposed increase in payment rates for rehabilitation hospitals by CMS and positive \"Overweight\" ratings from analysts like KeyBanc and Barclays. This upward movement occurred despite a recent securities fraud investigation, suggesting the market prioritized the favorable regulatory and analyst news. The company's strong Q4 2025 results also provided a positive financial foundation.", "sentiment_score": -0.127769, "sentiment_label": "Neutral", "relevance_score": 0.626244, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Biodesix Announces AACR 2026 Posters and Presentations,", "url": "https://www.globenewswire.com/news-release/2026/04/06/3268553/0/en/biodesix-announces-aacr-2026-posters-and-presentations-highlighting-novel-diagnostic-test-discovery-pipeline-development.html", "date": "2026-04-06", "summary": "Biodesix will present seven abstracts, including two oral sessions, at the American Association for Cancer Research (AACR) Annual Meeting in San Diego from April 17-22, 2026. The presentations will highlight the company's expertise in blood- and tissue-based testing for oncology, including novel diagnostic test discovery, pipeline development, and molecular residual disease (MRD) testing. The company will showcase its proteomic and genomic approaches, as well as its capabilities in immune and tu", "sentiment_score": 0.340646, "sentiment_label": "Somewhat-Bullish", "relevance_score": 0.723988, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Biodesix to Showcase Advances in Diagnostic Solutions at AACR Annual Meeting 2026", "url": "https://www.quiverquant.com/news/Biodesix+to+Showcase+Advances+in+Diagnostic+Solutions+at+AACR+Annual+Meeting+2026", "date": "2026-04-06", "summary": "Biodesix, Inc. will present seven abstracts, including two oral sessions, at the AACR Annual Meeting from April 17-22, 2026, in San Diego. The presentations will highlight the company's expertise in blood- and tissue-based diagnostic testing for cancer, focusing on advancements in genomic and proteomic technologies, tumor and immune profiling, and molecular residual disease monitoring. This includes the validation of a new clinical myeloid panel capable of delivering rapid sequencing results.", "sentiment_score": 0.144675, "sentiment_label": "Neutral", "relevance_score": 0.626334, "sentiment": { "label": "positive", "score": 0.178, "confidence": 0.18 } }, { "source": "alpha_vantage", "title": "Cancer test developer Biodesix brings 7 studies to AACR meeting", "url": "https://www.stocktitan.net/news/BDSX/biodesix-announces-aacr-2026-posters-and-presentations-highlighting-03imi1x9d1n7.html", "date": "2026-04-06", "summary": "Biodesix (Nasdaq: BDSX) announced it will present seven abstracts, including two oral sessions, at the AACR Annual Meeting in San Diego from April 17–22, 2026. The presentations will cover various aspects of cancer diagnostics, including blood- and tissue-based testing, tumor and immune profiling, and multi-omic molecular residual disease (MRD) pipeline development. This includes novel proteomic and genomic approaches leveraging technologies like mass spectrometry, Bio-Rad ddPCR, and Thermo Fish", "sentiment_score": 0.345568, "sentiment_label": "Somewhat-Bullish", "relevance_score": 0.71551, "sentiment": { "label": "negative", "score": -0.66, "confidence": 0.66 } }, { "source": "alpha_vantage", "title": "Biodesix Announces AACR 2026 Posters and Presentations", "url": "https://www.globenewswire.com/news-release/2026/04/06/3268553/0/en/Biodesix-Announces-AACR-2026-Posters-and-Presentations-Highlighting-Novel-Diagnostic-Test-Discovery-Pipeline-Development.html", "date": "2026-04-06", "summary": "Biodesix, Inc. will present seven abstracts, including two oral sessions, at the American Association for Cancer Research (AACR) Annual Meeting in San Diego, CA, from April 17 - 22, 2026. The presentations highlight the company's expertise in blood- and tissue-based testing, covering novel proteomic and genomic approaches for oncology therapeutic selection, response monitoring, and Molecular Residual Disease (MRD) testing. This demonstrates Biodesix's comprehensive capabilities from basic resear", "sentiment_score": 0.335923, "sentiment_label": "Somewhat-Bullish", "relevance_score": 0.707123, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Thermo Fisher Introduces Gibco CTS Compleo Fill and Finish System", "url": "https://www.contractpharma.com/breaking-news/thermo-fisher-introduces-gibco-cts-compleo-fill-and-finish-system/", "date": "2026-04-06", "summary": "Thermo Fisher Scientific has launched the Gibco CTS Compleo Fill and Finish System, an automated and functionally closed system designed to enhance cell therapy manufacturing. This system aims to streamline formulation and filling processes, reduce manual intervention, and improve consistency, addressing a significant bottleneck in the production of cell therapies. It is part of the Gibco Cell Therapy Systems portfolio, which provides integrated solutions to support GMP-compliant manufacturing.", "sentiment_score": 0.404561, "sentiment_label": "Bullish", "relevance_score": 1.0, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Blood Viscometer Market Is Going to Boom |• Thermo Fisher Scientific • Brookfield Engineering", "url": "https://www.openpr.com/news/4456723/blood-viscometer-market-is-going-to-boom-thermo-fisher", "date": "2026-04-06", "summary": "Worldwide Market Reports has released a comprehensive research study titled \"Blood Viscometer Market Size and Forecast 2026-2033,\" analyzing the market's expected growth using primary and secondary research methodologies. The report details key market drivers, challenges, opportunities, and restraints, and includes a competitive landscape overview with profiles of major players like Thermo Fisher Scientific and Brookfield Engineering. It segments the market by types and applications, provides a ", "sentiment_score": 0.304105, "sentiment_label": "Somewhat-Bullish", "relevance_score": 0.906557, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Genome Editing Market Is Going to Boom |• CRISPR Therapeutics • Editas Medicine", "url": "https://www.openpr.com/news/4456731/genome-editing-market-is-going-to-boom-crispr-therapeutics", "date": "2026-04-06", "summary": "Worldwide Market Reports has published a comprehensive analysis titled \"Genome Editing Market Size and Forecast 2026-2033,\" predicting significant growth in the genome editing sector. The report, based on extensive research, details market drivers, challenges, opportunities, and competitive landscapes, featuring key players like CRISPR Therapeutics and Editas Medicine. It offers crucial insights for stakeholders, covering market segmentation by types and applications, regional trends, and foreca", "sentiment_score": 0.301783, "sentiment_label": "Somewhat-Bullish", "relevance_score": 0.607639, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "sec", "filing_type": "8-K", "title": "8-K - Current report", "date": "2026-03-24", "url": "https://www.sec.gov/Archives/edgar/data/97745/000009774526000066/0000097745-26-000066-index.htm", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41965847", "title": "Impact of SARS-CoV-2 vaccination on monoclonal gammopathy of undetermined significance: results from the population-based iStopMM study.", "authors": "Palmason R et al.", "journal": "Blood cancer journal", "date": "2026 Apr 1", "url": "https://pubmed.ncbi.nlm.nih.gov/41965847/", "sentiment": { "label": "positive", "score": 0.273, "confidence": 0.27 } }, { "source": "pubmed", "pmid": "41965748", "title": "Experimental and computational methods for allelic imbalance analysis from single-nucleus RNA-seq data.", "authors": "Simmons SK et al.", "journal": "Genome biology", "date": "2026 Apr 1", "url": "https://pubmed.ncbi.nlm.nih.gov/41965748/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41963505", "title": "The role of the molecular tumor board: learnings from the ROME trial.", "authors": "Marchetti P et al.", "journal": "NPJ precision oncology", "date": "2026 Apr 1", "url": "https://pubmed.ncbi.nlm.nih.gov/41963505/", "sentiment": { "label": "negative", "score": -0.382, "confidence": 0.38 } }, { "source": "pubmed", "pmid": "41962871", "title": "An adaptive quantification scheme for profiling serum antibody level in transplant immunology.", "authors": "Schacker T et al.", "journal": "Transplant immunology", "date": "2026 Apr 8", "url": "https://pubmed.ncbi.nlm.nih.gov/41962871/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41960723", "title": "Treatment choice for chronic lymphocytic leukemia after covalent BTKi therapy: a patient and oncologist preference study.", "authors": "Michaels-Igbokwe C et al.", "journal": "Leukemia & lymphoma", "date": "2026 Apr 1", "url": "https://pubmed.ncbi.nlm.nih.gov/41960723/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41960557", "title": "Clinical phenotypes and molecular endotypes of chronic urticaria: Linking clinical expression to underlying immune mechanisms.", "authors": "Türk M et al.", "journal": "Asia Pacific allergy", "date": "2026 Apr 1", "url": "https://pubmed.ncbi.nlm.nih.gov/41960557/", "sentiment": { "label": "positive", "score": 0.296, "confidence": 0.3 } }, { "source": "pubmed", "pmid": "41957135", "title": "Impact of tumor location on the efficacy of concurrent chemoradiotherapy for locally advanced non-small cell lung cancer.", "authors": "Ozawa Y et al.", "journal": "British journal of cancer", "date": "2026 Apr 9", "url": "https://pubmed.ncbi.nlm.nih.gov/41957135/", "sentiment": { "label": "negative", "score": -0.718, "confidence": 0.72 } }, { "source": "pubmed", "pmid": "41953806", "title": "Melatonin promotes stomatal immunity by mediating phytohormone crosstalk in Arabidopsis thaliana.", "authors": "Li Y et al.", "journal": "Frontiers in plant science", "date": "2026-04-12", "url": "https://pubmed.ncbi.nlm.nih.gov/41953806/", "sentiment": { "label": "positive", "score": 0.34, "confidence": 0.34 } }, { "source": "pubmed", "pmid": "41951782", "title": "Reproductive hormone stability with prolonged intranasal oxytocin in adults with obesity.", "authors": "Galbiati F et al.", "journal": "International journal of obesity (2005)", "date": "2026 Apr 9", "url": "https://pubmed.ncbi.nlm.nih.gov/41951782/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41951141", "title": "Expanding the Global Map of Protein Post Translational Modifications with Immunoaffinity Enrichment and nDIA Analysis on the Orbitrap Astral Mass Spectrometer.", "authors": "Kumar M et al.", "journal": "Molecular & cellular proteomics : MCP", "date": "2026 Apr 6", "url": "https://pubmed.ncbi.nlm.nih.gov/41951141/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41950525", "title": "Toward Molecular Forensics of Agrochemicals with Orbitrap IRMS: Isotopic Fingerprints of Imidacloprid Sources and Elucidating Hydrolysis.", "authors": "Niemann F et al.", "journal": "Journal of the American Society for Mass Spectrometry", "date": "2026 Apr 8", "url": "https://pubmed.ncbi.nlm.nih.gov/41950525/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41950519", "title": "Cross-Sectional Imaging of the WS(2) Nanotube Formation Pathways.", "authors": "Bukvisova K et al.", "journal": "Nano letters", "date": "2026 Apr 8", "url": "https://pubmed.ncbi.nlm.nih.gov/41950519/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41947768", "title": "First 20 Years of Orbitrap Mass Spectrometry as the Mainstream Analytical Technique.", "authors": "Makarov A", "journal": "Mass spectrometry reviews", "date": "2026 Apr 8", "url": "https://pubmed.ncbi.nlm.nih.gov/41947768/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41938080", "title": "Clinical Concordance of Pan Lung Cancer PCR Panel Covering 167 Actionable Variants Across 11 Genes and Other Validated Assays in the LC-SCRUM-Asia Registry.", "authors": "Matsumoto S et al.", "journal": "JTO clinical and research reports", "date": "2026-04-12", "url": "https://pubmed.ncbi.nlm.nih.gov/41938080/", "sentiment": { "label": "negative", "score": -0.542, "confidence": 0.54 } }, { "source": "pubmed", "pmid": "41937341", "title": "Immediate and delayed hypersensitivity to biologicals in children-A practical approach: An EAACI task force report.", "authors": "Mori F et al.", "journal": "Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology", "date": "2026-04-12", "url": "https://pubmed.ncbi.nlm.nih.gov/41937341/", "sentiment": { "label": "negative", "score": -0.226, "confidence": 0.23 } }, { "source": "pubmed", "pmid": "41934444", "title": "Reply.", "authors": "Custovic D et al.", "journal": "The Journal of allergy and clinical immunology", "date": "2026 Apr 3", "url": "https://pubmed.ncbi.nlm.nih.gov/41934444/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41933068", "title": "Longer duration of amenorrhea is associated with lower delay discounting and less hedonic eating in girls and young women with low-weight eating disorders.", "authors": "Wronski ML et al.", "journal": "Scientific reports", "date": "2026 Apr 3", "url": "https://pubmed.ncbi.nlm.nih.gov/41933068/", "sentiment": { "label": "negative", "score": -0.542, "confidence": 0.54 } }, { "source": "pubmed", "pmid": "41929003", "title": "GlycoDiveR: a modular R framework to analyze and visualize highly dimensional glycoproteomics data.", "authors": "Veth TS et al.", "journal": "bioRxiv : the preprint server for biology", "date": "2026 Mar 2", "url": "https://pubmed.ncbi.nlm.nih.gov/41929003/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41928234", "title": "Transcriptomics analysis identifies folding and secretion related genes for improving monoclonal antibody production in Thermothelomyces heterothallica C1.", "authors": "Mäkinen M et al.", "journal": "Microbial cell factories", "date": "2026 Apr 2", "url": "https://pubmed.ncbi.nlm.nih.gov/41928234/", "sentiment": { "label": "positive", "score": 0.421, "confidence": 0.42 } }, { "source": "pubmed", "pmid": "41926944", "title": "[Use of Omalizumab-biosimilars for CRSwNP in the German Health Care System - a Position Paper of the German Societies for Allergy AeDA and ORL DGHNO-KHC].", "authors": "Klimek L et al.", "journal": "Laryngo- rhino- otologie", "date": "2026-04-12", "url": "https://pubmed.ncbi.nlm.nih.gov/41926944/", "sentiment": { "label": "positive", "score": 0.494, "confidence": 0.49 } }, { "source": "pubmed", "pmid": "41925420", "title": "Harnessing the lung microbiome for precision management of fibrotic lung disease.", "authors": "Leroy S et al.", "journal": "Trends in molecular medicine", "date": "2026 Mar 3", "url": "https://pubmed.ncbi.nlm.nih.gov/41925420/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41923638", "title": "Learning multi-cellular representations of single-cell transcriptomics data enables characterization of patient-level disease states.", "authors": "Liu T et al.", "journal": "Cell systems", "date": "2026 Mar 3", "url": "https://pubmed.ncbi.nlm.nih.gov/41923638/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41920124", "title": "Revisiting age- and sex-dependent serum tryptase reference intervals: Is additional evidence needed to refine current estimates?", "authors": "Chantran Y et al.", "journal": "The Journal of allergy and clinical immunology", "date": "2026 Apr 1", "url": "https://pubmed.ncbi.nlm.nih.gov/41920124/", "sentiment": { "label": "negative", "score": -0.2, "confidence": 0.2 } }, { "source": "pubmed", "pmid": "41919739", "title": "Implementing Annotation Confidence Scoring in Untargeted Mass Spectrometry Workflows for Small Molecule Analysis.", "authors": "Krakko D et al.", "journal": "Analytical chemistry", "date": "2026 Apr 1", "url": "https://pubmed.ncbi.nlm.nih.gov/41919739/", "sentiment": { "label": "positive", "score": 0.511, "confidence": 0.51 } }, { "source": "pubmed", "pmid": "41918709", "title": "Modelling lowering of raised blood pressure in pregnancy to reduce pre-eclampsia: secondary analysis of data from prospective cohort studies.", "authors": "Wright A et al.", "journal": "BMJ medicine", "date": "2026-04-12", "url": "https://pubmed.ncbi.nlm.nih.gov/41918709/", "sentiment": { "label": "negative", "score": -0.494, "confidence": 0.49 } }, { "source": "pubmed", "pmid": "41917520", "title": "Associations Between Different Eosinophil Activity Markers and Clinical Outcomes in Young Asthmatics.", "authors": "Jõgi NO et al.", "journal": "Clinical and translational allergy", "date": "2026-04-12", "url": "https://pubmed.ncbi.nlm.nih.gov/41917520/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41915787", "title": "An increased number of heterozygous calls in the AxiomTM Equine Genotyping Array.", "authors": "Gmel AI et al.", "journal": "G3 (Bethesda, Md.)", "date": "2026 Mar 3", "url": "https://pubmed.ncbi.nlm.nih.gov/41915787/", "sentiment": { "label": "positive", "score": 0.34, "confidence": 0.34 } }, { "source": "pubmed", "pmid": "41913717", "title": "Visualization of Multi-indication Randomized Control Trial Evidence to Support Decision Making in Oncology: A Case Study on Bevacizumab.", "authors": "Anwer S et al.", "journal": "Medical decision making : an international journal of the Society for Medical Decision Making", "date": "2026 Mar 3", "url": "https://pubmed.ncbi.nlm.nih.gov/41913717/", "sentiment": { "label": "positive", "score": 0.402, "confidence": 0.4 } }, { "source": "pubmed", "pmid": "41912495", "title": "Revised criteria for light chain MGUS enhance diagnostic accuracy and risk stratification.", "authors": "Andersen LS et al.", "journal": "Blood cancer journal", "date": "2026 Mar 3", "url": "https://pubmed.ncbi.nlm.nih.gov/41912495/", "sentiment": { "label": "negative", "score": -0.273, "confidence": 0.27 } }, { "source": "pubmed", "pmid": "41910757", "title": "[Olanzapine long acting injectable in new application form-Hope for the absence of post-injection delirium/sedation syndromes].", "authors": "Paulzen M et al.", "journal": "Der Nervenarzt", "date": "2026 Mar 3", "url": "https://pubmed.ncbi.nlm.nih.gov/41910757/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41910519", "title": "Reply.", "authors": "Gattinger P et al.", "journal": "The Journal of allergy and clinical immunology", "date": "2026 Mar 3", "url": "https://pubmed.ncbi.nlm.nih.gov/41910519/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41903301", "title": "Phase Ia/Ib trial of the safety and efficacy of mobocertinib in combination with T-DM1 for patients with HER2-mutant solid tumors (WJOG16022M).", "authors": "Kanemura H et al.", "journal": "European journal of cancer (Oxford, England : 1990)", "date": "2026 May 2", "url": "https://pubmed.ncbi.nlm.nih.gov/41903301/", "sentiment": { "label": "positive", "score": 0.527, "confidence": 0.53 } }, { "source": "pubmed", "pmid": "41903103", "title": "Potential Public Health Impact of Updated COVID-19 Vaccination Strategies in Thailand: Epidemiological Data Update.", "authors": "Thakkar K et al.", "journal": "Pulmonary therapy", "date": "2026 Mar 2", "url": "https://pubmed.ncbi.nlm.nih.gov/41903103/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41898871", "title": "Internal Validation of a Mitochondrial DNA Control Region Sequencing Workflow Using Precision ID mtDNA Whole Genome Panel, Ion Chef™ System and Ion S5™ XL System.", "authors": "Shue BH et al.", "journal": "Genes", "date": "2026 Mar 1", "url": "https://pubmed.ncbi.nlm.nih.gov/41898871/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41898311", "title": "Integration of RNA Editing into Multiomics Machine Learning Models for Predicting Drug Responses in Breast Cancer Patients.", "authors": "Bernal YA et al.", "journal": "Biomedicines", "date": "2026 Mar 1", "url": "https://pubmed.ncbi.nlm.nih.gov/41898311/", "sentiment": { "label": "negative", "score": -0.66, "confidence": 0.66 } }, { "source": "pubmed", "pmid": "41896400", "title": "Post-COVID-19 Burden of Severe Influenza in England Among Overall Population and High-Risk Groups: Results From the INFORM Study, 2022-2023.", "authors": "Meeraus W et al.", "journal": "Infectious diseases and therapy", "date": "2026 Mar 2", "url": "https://pubmed.ncbi.nlm.nih.gov/41896400/", "sentiment": { "label": "negative", "score": -0.67, "confidence": 0.67 } }, { "source": "pubmed", "pmid": "41895568", "title": "Accumulation patterns of polychlorinated alkanes in an Arctic marine food web.", "authors": "Giebichenstein J et al.", "journal": "Environmental research", "date": "2026 Mar 2", "url": "https://pubmed.ncbi.nlm.nih.gov/41895568/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41890053", "title": "UFMylation of Pyruvate Dehydrogenase Regulates Mitochondrial Metabolism.", "authors": "Nguyen PT et al.", "journal": "bioRxiv : the preprint server for biology", "date": "2026 Mar 1", "url": "https://pubmed.ncbi.nlm.nih.gov/41890053/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41887965", "title": "Influence of computed tomography reconstruction algorithms on coronary artery calcium scores and reader agreement.", "authors": "Yang LD et al.", "journal": "Journal of cardiovascular computed tomography", "date": "2026 Mar 2", "url": "https://pubmed.ncbi.nlm.nih.gov/41887965/", "sentiment": { "label": "positive", "score": 0.494, "confidence": 0.49 } }, { "source": "pubmed", "pmid": "41887157", "title": "Corrigendum to \"Systemic distribution and transplacental transfer of micro- and nanoplastics in a filter-feeding marine predator\" [Environ. Res. Volume 298, 1 June 2026, 124237].", "authors": "Ruiz-Sagalés M et al.", "journal": "Environmental research", "date": "2026 Mar 2", "url": "https://pubmed.ncbi.nlm.nih.gov/41887157/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41886673", "title": "Oral nutritional interventions in hospitalised older people at nutritional risk: a network meta-analysis of individual participant data.", "authors": "Kiesswetter E et al.", "journal": "The Cochrane database of systematic reviews", "date": "2026 Mar 2", "url": "https://pubmed.ncbi.nlm.nih.gov/41886673/", "sentiment": { "label": "negative", "score": -0.273, "confidence": 0.27 } }, { "source": "pubmed", "pmid": "41884877", "title": "Combined Nutritional and Exercise Interventions for Cachexia in Chronic Diseases: A Systematic Review and Meta-analysis Limited to Cancer Cachexia.", "authors": "Okamura M et al.", "journal": "Progress in rehabilitation medicine", "date": "2026-04-12", "url": "https://pubmed.ncbi.nlm.nih.gov/41884877/", "sentiment": { "label": "negative", "score": -0.743, "confidence": 0.74 } }, { "source": "pubmed", "pmid": "41882535", "title": "Metabolic dysfunction-associated steatohepatitis in the real world: clinical burden, disease progression, and risk stratification with non-invasive tests.", "authors": "Sartini C et al.", "journal": "BMC gastroenterology", "date": "2026 Mar 2", "url": "https://pubmed.ncbi.nlm.nih.gov/41882535/", "sentiment": { "label": "negative", "score": -0.612, "confidence": 0.61 } }, { "source": "pubmed", "pmid": "41882365", "title": "Electrochemical corrosion accompanies dendrite growth in solid electrolytes.", "authors": "Fincher CD et al.", "journal": "Nature", "date": "2026 Mar 2", "url": "https://pubmed.ncbi.nlm.nih.gov/41882365/", "sentiment": { "label": "positive", "score": 0.494, "confidence": 0.49 } }, { "source": "pubmed", "pmid": "41880124", "title": "Development of the Patient Satisfaction with Medication for Diabetes (PSMD) questionnaire.", "authors": "Boye KS et al.", "journal": "Journal of patient-reported outcomes", "date": "2026 Mar 2", "url": "https://pubmed.ncbi.nlm.nih.gov/41880124/", "sentiment": { "label": "positive", "score": 0.44, "confidence": 0.44 } }, { "source": "pubmed", "pmid": "41879365", "title": "Giant Magnetostriction in Ferrimagnetic SmFe(5)As(3).", "authors": "Karychort O et al.", "journal": "Angewandte Chemie (International ed. in English)", "date": "2026 Mar 2", "url": "https://pubmed.ncbi.nlm.nih.gov/41879365/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "pubmed", "pmid": "41878748", "title": "Characteristics of Adult Severe Uncontrolled Asthma Patients in Primary Care and Modifications in Prescribed Inhalation Treatments.", "authors": "Konradsen JR et al.", "journal": "Journal of asthma and allergy", "date": "2026-04-12", "url": "https://pubmed.ncbi.nlm.nih.gov/41878748/", "sentiment": { "label": "negative", "score": -0.103, "confidence": 0.1 } }, { "source": "pubmed", "pmid": "41876063", "title": "Asthma Impairment and Risk Questionnaire predicts short- and long-term exacerbation occurrence across asthma severities.", "authors": "McCann WA et al.", "journal": "Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology", "date": "2026 Mar 2", "url": "https://pubmed.ncbi.nlm.nih.gov/41876063/", "sentiment": { "label": "negative", "score": -0.273, "confidence": 0.27 } }, { "source": "pubmed", "pmid": "41874648", "title": "Real-world effectiveness of avelumab, pembrolizumab, and enfortumab vedotin in patients with advanced urothelial carcinoma with squamous differentiation (ARON-2EV).", "authors": "Mollica V et al.", "journal": "Cancer immunology, immunotherapy : CII", "date": "2026 Mar 2", "url": "https://pubmed.ncbi.nlm.nih.gov/41874648/", "sentiment": { "label": "positive", "score": 0.25, "confidence": 0.25 } }, { "source": "pubmed", "pmid": "41870027", "title": "Automated Online Direct mRNA Sequence Mapping Using Partial RNase T1 Digests.", "authors": "Dale JS et al.", "journal": "Analytical chemistry", "date": "2026 Apr 7", "url": "https://pubmed.ncbi.nlm.nih.gov/41870027/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "news", "source_name": "PR Newswire UK", "title": "Global Metabolomics Market Poised for Strong Growth as Advancements in Precision Medicine and Biomarker Discovery Accelerate Adoption: Verified Market Research®", "description": "The global metabolomics market is witnessing steady expansion driven by rising demand for precision medicine, biomarker discovery, and systems biology research. Technological advancements in mass spectrometry and nuclear magnetic resonance (NMR), coupled with…", "url": "https://www.prnewswire.co.uk/news-releases/global-metabolomics-market-poised-for-strong-growth-as-advancements-in-precision-medicine-and-biomarker-discovery-accelerate-adoption-verified-market-research-302739224.html", "date": "2026-04-10", "published_at": "2026-04-10T16:52:00Z", "sentiment": { "label": "positive", "score": 0.951, "confidence": 0.95 } }, { "source": "news", "source_name": "Plos.org", "title": "Casein kinase 2-mediated phosphorylation of the splicing factor SF3B3 plays a key role in esophageal squamous cell carcinoma progression", "description": "Protein kinases play a crucial role in regulating cellular processes, and their dysregulation is frequently implicated in various diseases, including cancer. This study shows that casein kinase 2-mediated phosphorylation of the splicing factor SF3B2 enhances …", "url": "https://journals.plos.org/plosbiology/article?id=10.1371/journal.pbio.3003729", "date": "2026-04-10", "published_at": "2026-04-10T14:00:00Z", "sentiment": { "label": "negative", "score": -0.25, "confidence": 0.25 } }, { "source": "news", "source_name": "Plos.org", "title": "Structural insights into subtype-specific agonist recognition by sphingosine-1-phosphate receptors", "description": "Sphingosine-1-phosphate receptors (S1PRs) play complex roles in several pathological processes, which has led to the development of pharmacological modulators. This study solves the cryo-EM structures of four agonist-bound S1PR1-Gi1 complexes and reveals the …", "url": "https://journals.plos.org/plosbiology/article?id=10.1371/journal.pbio.3003381", "date": "2026-04-10", "published_at": "2026-04-10T14:00:00Z", "sentiment": { "label": "positive", "score": 0.542, "confidence": 0.54 } }, { "source": "news", "source_name": "Plos.org", "title": "Cytotoxic Vδ2+ T cell subsets expand in response to malaria in human tonsil and spleen organoids", "description": "Author summary Plasmodium falciparum (Pf) malaria vaccines are significantly less effective in populations with endemic malaria exposure compared to malaria-naïve individuals. We used human tonsil and spleen organoids to investigate whether Pf infection alter…", "url": "https://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1013565", "date": "2026-04-10", "published_at": "2026-04-10T14:00:00Z", "sentiment": { "label": "positive", "score": 0.626, "confidence": 0.63 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Immunohistochemistry Market Led by Diagnostics Segment with 60%+ Share; Market Projected to Reach USD 4.42 billion by 2031, Mordor Intelligence Reports", "description": "Immunohistochemistry demand grows in oncology diagnostics and digital pathology as companies like Thermo Fisher, Roche, Agilent and Merck drive innovation.", "url": "https://www.globenewswire.com/news-release/2026/04/10/3271669/0/en/Immunohistochemistry-Market-Led-by-Diagnostics-Segment-with-60-Share-Market-Projected-to-Reach-USD-4-42-billion-by-2031-Mordor-Intelligence-Reports.html", "date": "2026-04-10", "published_at": "2026-04-10T11:14:00Z", "sentiment": { "label": "positive", "score": 1.0, "confidence": 1.0 } }, { "source": "news", "source_name": "Singletracks.com", "title": "The Monarch Crest Trail’s doubletrack downhill is being replaced with 1.8 miles of singletrack", "description": "After years of losing precious vert on a dusty mining road, riders will soon have a purpose-built singletrack descent wrapping around the flanks of Mount Ouray.\nThe article The Monarch Crest Trail’s doubletrack downhill is being replaced with 1.8 miles of sin…", "url": "https://www.singletracks.com/?p=716032", "date": "2026-04-10", "published_at": "2026-04-10T10:02:00Z", "sentiment": { "label": "positive", "score": 0.273, "confidence": 0.27 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Global Next-Generation Sequencing (NGS) Market to Double in Size by 2030 - Asia-Pacific NGS Market Poised for Fastest Growth, Driven by Large-Scale Genomic Projects and the Rising Need for Precision Medicine", "description": "Dublin, April 10, 2026 (GLOBE NEWSWIRE) -- The \"Next-Generation Sequencing Market by Product Type, Technology, Workflow, Services, Application - Global Forecast to 2030\" has been added to ResearchAndMarkets.com's offering.The next-generation sequencing (NGS) …", "url": "https://www.globenewswire.com/news-release/2026/04/10/3271604/28124/en/Global-Next-Generation-Sequencing-NGS-Market-to-Double-in-Size-by-2030-Asia-Pacific-NGS-Market-Poised-for-Fastest-Growth-Driven-by-Large-Scale-Genomic-Projects-and-the-Rising-Need-.html", "date": "2026-04-10", "published_at": "2026-04-10T09:45:00Z", "sentiment": { "label": "positive", "score": 0.557, "confidence": 0.56 } }, { "source": "news", "source_name": "Pypi.org", "title": "teradatamodelops 7.2.6", "description": "Python client for Teradata ModelOps (TMO)", "url": "https://pypi.org/project/teradatamodelops/7.2.6/", "date": "2026-04-09", "published_at": "2026-04-09T22:43:16Z", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "news", "source_name": "Pypi.org", "title": "teradatamodelops 7.2.5", "description": "Python client for Teradata ModelOps (TMO)", "url": "https://pypi.org/project/teradatamodelops/7.2.5/", "date": "2026-04-09", "published_at": "2026-04-09T19:40:52Z", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "news", "source_name": "Cdc.gov", "title": "Emergence of Extensively Drug-Resistant Shigellosis - United States, 2011-2023", "description": "This report describes the emergence of drug-resistant shigellosis in the United States during 2011-2023.", "url": "https://www.cdc.gov/mmwr/volumes/75/wr/mm7513a1.htm", "date": "2026-04-09", "published_at": "2026-04-09T17:00:00Z", "sentiment": { "label": "positive", "score": 0.681, "confidence": 0.68 } }, { "source": "news", "source_name": "RTE", "title": "W6N: England v Ireland - All You Need to Know", "description": "It's been a long old wait since last year's Rugby World Cup, and what a way to kick off this Guinness Women's Six Nations.", "url": "https://www.rte.ie/sport/rugby/2026/0409/1567428-w6n-england-v-ireland-all-you-need-to-know/", "date": "2026-04-09", "published_at": "2026-04-09T14:23:13Z", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Global Noninvasive Cancer Diagnostics Market to Reach $165.2 Billion by 2030 as Liquid Biopsy, AI-Enabled Screening and Multi-Cancer Detection Tests Transform Oncology", "description": "Market growth is driven by rising cancer prevalence, demand for minimally invasive procedures, and advances in precision diagnostics....", "url": "https://www.globenewswire.com/news-release/2026/04/09/3271135/0/en/Global-Noninvasive-Cancer-Diagnostics-Market-to-Reach-165-2-Billion-by-2030-as-Liquid-Biopsy-AI-Enabled-Screening-and-Multi-Cancer-Detection-Tests-Transform-Oncology.html", "date": "2026-04-09", "published_at": "2026-04-09T14:12:00Z", "sentiment": { "label": "negative", "score": -0.823, "confidence": 0.82 } }, { "source": "news", "source_name": "Plos.org", "title": "Antibacterial potential of epiphytic fungi obtained from brown algae of Kenyan coastal waters", "description": "The rapid rise of antimicrobial resistance, coupled with the limited development of new therapeutic agents, is a critical public health concern that needs urgent and innovative interventions. Marine fungi represent an important but still largely unexplored so…", "url": "https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0346865", "date": "2026-04-09", "published_at": "2026-04-09T14:00:00Z", "sentiment": { "label": "positive", "score": 0.166, "confidence": 0.17 } }, { "source": "news", "source_name": "Plos.org", "title": "Accumulation of mutations in nsp4, E, and the S2 subunit underlies mammalian cell tropism expansion and virulence attenuation of avian coronavirus", "description": "Author summary Infectious bronchitis virus (IBV), a member of the γ-coronavirus genus, is primarily controlled via live attenuated vaccines. However, the production of these vaccines depends on embryonated chicken eggs, which are plagued by supply constraints…", "url": "https://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1014147", "date": "2026-04-09", "published_at": "2026-04-09T14:00:00Z", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "news", "source_name": "Plos.org", "title": "Whole genome and phylogenomic insights into Vibrio parahaemolyticus from Pacific White Shrimp reveal resistance and virulence traits in Bangladeshi aquaculture", "description": "The fisheries sector of Bangladesh has significantly contributed to the national economy and provided livelihoods for millions of rural households. However, disease outbreaks and contamination of fish by Vibrio species pose significant hurdles to production a…", "url": "https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0346962", "date": "2026-04-09", "published_at": "2026-04-09T14:00:00Z", "sentiment": { "label": "positive", "score": 0.402, "confidence": 0.4 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "AI-Powered Pharma Manufacturing Signals Scalable Efficiency, Long-Term Cost Advantages", "description": "AUSTIN, Texas, April 09, 2026 (GLOBE NEWSWIRE) -- AINewsWire Editorial Coverage\r\n: As regulatory demands intensify and production environments become more complex, pharmaceutical manufacturers are shifting beyond traditional quality assurance systems toward a…", "url": "https://www.globenewswire.com/news-release/2026/04/09/3270963/0/en/AI-Powered-Pharma-Manufacturing-Signals-Scalable-Efficiency-Long-Term-Cost-Advantages.html", "date": "2026-04-09", "published_at": "2026-04-09T12:30:00Z", "sentiment": { "label": "positive", "score": 0.751, "confidence": 0.75 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Indoor Air Quality Monitor Market Size to Grow $11.84 Billion by 2035 | SNS Insider", "description": "Indoor Air Quality Monitor Market Size, Share, Trends & Segment, by Pollutant Type, Product Type, Technology, End User, and Region | Global Forecast 2035...", "url": "https://www.globenewswire.com/news-release/2026/04/09/3270813/0/en/Indoor-Air-Quality-Monitor-Market-Size-to-Grow-11-84-Billion-by-2035-SNS-Insider.html", "date": "2026-04-09", "published_at": "2026-04-09T11:30:00Z", "sentiment": { "label": "positive", "score": 0.296, "confidence": 0.3 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "$1.05 Bn Biopharmaceutical CXO Markets - Global Forecast Report 2026-2032: How Leading Pharmas Such as Pfizer, Roche, Novartis, Sanofi, and AstraZeneca Navigate the Evolving Dynamics", "description": "The biopharmaceutical CXO market offers opportunities in strategic outsourcing, digital integration, resilient supply chains, and value-driven partnerships amidst evolving regulatory landscapes. The biopharmaceutical CXO market offers opportunities in strateg…", "url": "https://www.globenewswire.com/news-release/2026/04/09/3270735/28124/en/1-05-Bn-Biopharmaceutical-CXO-Markets-Global-Forecast-Report-2026-2032-How-Leading-Pharmas-Such-as-Pfizer-Roche-Novartis-Sanofi-and-AstraZeneca-Navigate-the-Evolving-Dynamics.html", "date": "2026-04-09", "published_at": "2026-04-09T10:05:00Z", "sentiment": { "label": "positive", "score": 0.943, "confidence": 0.94 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Active Pharmaceutical Ingredients CDMO Market Research and Global Forecast Report 2025-2032: Exploring Service Models, Analytical Services, Process Developments, and More", "description": "The API CDMO market presents opportunities in outsourcing, flexible solutions, and strategic partnerships, driven by regulatory complexity, technology adoption, and shifting supplier dynamics. The API CDMO market presents opportunities in outsourcing, flexibl…", "url": "https://www.globenewswire.com/news-release/2026/04/09/3270705/28124/en/Active-Pharmaceutical-Ingredients-CDMO-Market-Research-and-Global-Forecast-Report-2025-2032-Exploring-Service-Models-Analytical-Services-Process-Developments-and-More.html", "date": "2026-04-09", "published_at": "2026-04-09T09:09:00Z", "sentiment": { "label": "positive", "score": 1.0, "confidence": 1.0 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Biopharmaceutical Third Party Logistics (Distribution Management, Packaging & Labeling, Transportation, Warehousing) Market Research and Global Forecast Report 2026-2032", "description": "New therapies and regulations are redefining biopharma logistics, creating opportunities in cold chain integrity, digital tracking, and strategic vendor collaborations globally. New therapies and regulations are redefining biopharma logistics, creating opport…", "url": "https://www.globenewswire.com/news-release/2026/04/09/3270697/28124/en/Biopharmaceutical-Third-Party-Logistics-Distribution-Management-Packaging-Labeling-Transportation-Warehousing-Market-Research-and-Global-Forecast-Report-2026-2032.html", "date": "2026-04-09", "published_at": "2026-04-09T08:49:00Z", "sentiment": { "label": "positive", "score": 0.883, "confidence": 0.88 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Pharma B2B ECommerce Global Market Forecast 2026-2032 - Opportunities Lie in Digital Integration, Resilient Supply Chains, Real-time Transparency, and Compliance", "description": "The market opportunities lie in digital integration, resilient supply chains, real-time transparency, and compliance through technology, enabling dynamic, scalable, and efficient B2B pharmaceutical operations. The market opportunities lie in digital integrati…", "url": "https://www.globenewswire.com/news-release/2026/04/09/3270685/28124/en/Pharma-B2B-ECommerce-Global-Market-Forecast-2026-2032-Opportunities-Lie-in-Digital-Integration-Resilient-Supply-Chains-Real-time-Transparency-and-Compliance.html", "date": "2026-04-09", "published_at": "2026-04-09T08:02:00Z", "sentiment": { "label": "positive", "score": 0.904, "confidence": 0.9 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Flow Cytometry Market Set to Surpass USD 12.19 Billion by 2035, Driven by Rising Demand for Precision Diagnostics – SNS Insider", "description": "Austin, United States, April 08, 2026 (GLOBE NEWSWIRE) -- SNS Insider reported that global Flow Cytometry Market was valued at USD 5.75 billion in 2025 and is expected to reach USD 12.19 billion by 2035, growing at a CAGR of 7.8% over the forecast period of 2…", "url": "https://www.globenewswire.com/news-release/2026/04/08/3270347/0/en/Flow-Cytometry-Market-Set-to-Surpass-USD-12-19-Billion-by-2035-Driven-by-Rising-Demand-for-Precision-Diagnostics-SNS-Insider.html", "date": "2026-04-08", "published_at": "2026-04-08T15:33:00Z", "sentiment": { "label": "positive", "score": 0.718, "confidence": 0.72 } }, { "source": "news", "source_name": "Plos.org", "title": "Generation of a HiBiT-expressing recombinant rat hepacivirus supporting both in vivo and in vitro infection", "description": "Author summary Hepatitis C virus (HCV) infects millions of people and causes severe liver diseases, yet vaccine development has been hindered by the lack of practical small-animal models with intact immunity. Hepacivirus ratti (NRHV1), a close relative of HCV…", "url": "https://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1014127", "date": "2026-04-08", "published_at": "2026-04-08T14:00:00Z", "sentiment": { "label": "negative", "score": -0.052, "confidence": 0.05 } }, { "source": "news", "source_name": "Plos.org", "title": "Cetacean coronavirus spikes highlight S glycoprotein structural plasticity", "description": "Author summary Coronaviruses are well known for their ability to jump between species, a process driven mainly by the spike protein on their surface. In this study, we examined spike proteins from coronaviruses found in marine mammals (whales and dolphins) to…", "url": "https://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1013855", "date": "2026-04-08", "published_at": "2026-04-08T14:00:00Z", "sentiment": { "label": "positive", "score": 0.7, "confidence": 0.7 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Biopharmaceuticals Contract Manufacturing Market Global Forecast Report 2026-2032: A Cornerstone for Operational Efficiency, Agility, and Strategic Focus Amid a Rapidly Evolving Therapeutic Landscape", "description": "Biopharma contract manufacturing offers strategic agility, innovation in automation, regional diversification, and scalable solutions, enhancing market entry and supply chain resilience. Biopharma contract manufacturing offers strategic agility, innovation in…", "url": "https://www.globenewswire.com/news-release/2026/04/08/3269903/28124/en/Biopharmaceuticals-Contract-Manufacturing-Market-Global-Forecast-Report-2026-2032-A-Cornerstone-for-Operational-Efficiency-Agility-and-Strategic-Focus-Amid-a-Rapidly-Evolving-Thera.html", "date": "2026-04-08", "published_at": "2026-04-08T09:41:00Z", "sentiment": { "label": "positive", "score": 1.0, "confidence": 1.0 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Pharmaceutical Excipient Market - Global Forecast 2026-2032: Growth Driven by Innovation, Compliance Needs, and Digital Procurement with Emphasis on Supply Resilience, and Sustainability,", "description": "Excipient market growth driven by innovation, compliance needs, and digital procurement, with emphasis on supply resilience, sustainability, and adaptation to tariff changes. Excipient market growth driven by innovation, compliance needs, and digital procurem…", "url": "https://www.globenewswire.com/news-release/2026/04/08/3269875/28124/en/Pharmaceutical-Excipient-Market-Global-Forecast-2026-2032-Growth-Driven-by-Innovation-Compliance-Needs-and-Digital-Procurement-with-Emphasis-on-Supply-Resilience-and-Sustainability.html", "date": "2026-04-08", "published_at": "2026-04-08T09:07:00Z", "sentiment": { "label": "positive", "score": 1.0, "confidence": 1.0 } }, { "source": "news", "source_name": "Nature.com", "title": "Saturation editing of RNU4-2 reveals distinct dominant and recessive disorders", "description": "Saturation genome editing of RNU4-2 identifies the functional and clinical impact of variants across the entire gene and delineates variants that cause a new recessive neurodevelopmental disorder distinct from ReNU syndrome.", "url": "https://www.nature.com/articles/s41586-026-10334-9", "date": "2026-04-08", "published_at": "2026-04-08T00:00:00Z", "sentiment": { "label": "negative", "score": -0.402, "confidence": 0.4 } }, { "source": "news", "source_name": "Nature.com", "title": "Synthetic super-enhancers enable precision viral immunotherapy", "description": "Synthetic super-enhancers enable specific delivery of anticancer payloads, achieving tumour elimination after a single dose in a mouse model of aggressive glioblastoma.", "url": "https://www.nature.com/articles/s41586-026-10329-6", "date": "2026-04-08", "published_at": "2026-04-08T00:00:00Z", "sentiment": { "label": "negative", "score": -0.153, "confidence": 0.15 } }, { "source": "news", "source_name": "Mjtsai.com", "title": "John Martellaro, RIP", "description": "Bryan Chaffin: He rose to the rank of Captain in the U.S. Air Force, and he was a NASA scientist. He worked for years at Apple, and most importantly to me, he was a columnist and the voice of reason and humanity at The Mac Observer. He wrote SciFi and a varie…", "url": "https://mjtsai.com/blog/2026/04/07/john-martellaro-rip/", "date": "2026-04-07", "published_at": "2026-04-07T22:53:20Z", "sentiment": { "label": "positive", "score": 0.38, "confidence": 0.38 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Global DNA Read, Write and Edit Market to Surge to $67.7 Billion by 2030, Driven by CRISPR Advances, Genomic Diagnostics and Expanding Clinical Applications", "description": "Rapid expansion in clinical applications, rising demand for genomic diagnostics, and increased investment in CRISPR-based therapeutics are fueling demand....", "url": "https://www.globenewswire.com/news-release/2026/04/07/3269543/0/en/Global-DNA-Read-Write-and-Edit-Market-to-Surge-to-67-7-Billion-by-2030-Driven-by-CRISPR-Advances-Genomic-Diagnostics-and-Expanding-Clinical-Applications.html", "date": "2026-04-07", "published_at": "2026-04-07T17:44:00Z", "sentiment": { "label": "neutral", "score": 0.026, "confidence": 0.03 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Rapid Growth in Cell-Free Tumor DNA Detection Market: Forecast to Reach $5.64 Billion by 2030 as Advancements in Personalized Medicine Propel Expansion", "description": "Dublin, April 07, 2026 (GLOBE NEWSWIRE) -- The \"Cell Free Tumor Deoxyribonucleic Acid (DNA) Detection Market Report 2026\" has been added to ResearchAndMarkets.com's offering.", "url": "https://www.globenewswire.com/news-release/2026/04/07/3269503/28124/en/Rapid-Growth-in-Cell-Free-Tumor-DNA-Detection-Market-Forecast-to-Reach-5-64-Billion-by-2030-as-Advancements-in-Personalized-Medicine-Propel-Expansion.html", "date": "2026-04-07", "published_at": "2026-04-07T16:23:00Z", "sentiment": { "label": "positive", "score": 0.202, "confidence": 0.2 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Molecular Tumor Board Solutions Market Outlook 2026-2030 & 2035 with Competitor Market Share Data", "description": "Key growth factors include expanding precision oncology programs, genomic data integration, and cloud deployment in healthcare, with strong potential in Asia-Pacific Key growth factors include expanding precision oncology programs, genomic data integration, a…", "url": "https://www.globenewswire.com/news-release/2026/04/07/3269500/28124/en/Molecular-Tumor-Board-Solutions-Market-Outlook-2026-2030-2035-with-Competitor-Market-Share-Data.html", "date": "2026-04-07", "published_at": "2026-04-07T16:15:00Z", "sentiment": { "label": "positive", "score": 0.832, "confidence": 0.83 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Global Biopreservation Market Analysis by Product Type, Application, End User, and Region, 2025-2035: Cell and Gene Therapies Drive Biopreservation Demand", "description": "Dublin, April 07, 2026 (GLOBE NEWSWIRE) -- The \"Biopreservation Market - A Global and Regional Analysis: Product Type, Application, End User, and Regional Analysis - Analysis and Forecast, 2025-2035\" has been added to ResearchAndMarkets.com's offering.", "url": "https://www.globenewswire.com/news-release/2026/04/07/3269491/28124/en/Global-Biopreservation-Market-Analysis-by-Product-Type-Application-End-User-and-Region-2025-2035-Cell-and-Gene-Therapies-Drive-Biopreservation-Demand.html", "date": "2026-04-07", "published_at": "2026-04-07T16:04:00Z", "sentiment": { "label": "negative", "score": -0.128, "confidence": 0.13 } }, { "source": "news", "source_name": "Plos.org", "title": "Multifaceted bioactivity of brown seaweed-derived fucoidan from the Indian Coastline: A natural health product candidate", "description": "Brown seaweeds are rich in bioactive constituents, among which fucoidan a sulphated polysaccharide is particularly noted for its broad-spectrum therapeutic properties. This study explores the multifaceted bioactivity of fucoidan extracted from six brown seawe…", "url": "https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0346712", "date": "2026-04-07", "published_at": "2026-04-07T14:00:00Z", "sentiment": { "label": "positive", "score": 0.727, "confidence": 0.73 } }, { "source": "news", "source_name": "Plos.org", "title": "GM-CSF orchestrates monocyte and granulocyte responses to Cryptococcus gattii", "description": "Author summary Cryptococcus gattii is an environmental fungus that can cause severe lung and brain infections after inhalation through the respiratory tract. C. gattii causes disease in patients with known immune deficits but also in individuals that are appa…", "url": "https://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1013418", "date": "2026-04-07", "published_at": "2026-04-07T14:00:00Z", "sentiment": { "label": "negative", "score": -0.052, "confidence": 0.05 } }, { "source": "news", "source_name": "Plos.org", "title": "Genomic characterisation of Crimean-Congo haemorrhagic fever virus (CCHFV) in Tajikistan identifies a novel reassortant virus", "description": "Author summary Crimean-Congo haemorrhagic fever (CCHF) is a severe haemorrhagic disease caused by CCHF virus. The virus is found in Europe, Africa and Asia, and is predominantly transmitted by Hyalomma ticks. The negative-sense RNA genome is highly diverse an…", "url": "https://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0014204", "date": "2026-04-07", "published_at": "2026-04-07T14:00:00Z", "sentiment": { "label": "negative", "score": -0.077, "confidence": 0.08 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Elemental Analysis Market to Surpass USD 5.18 Billion by 2035, Driven by Rising Demand for Precise Material Characterization | SNS Insider", "description": "The Elemental Analysis Market is expanding as industries prioritize quality control and regulatory compliance, with the U.S. segment growing from USD 0.82 billion in 2025 to USD 1.45 billion by 2035. The Elemental Analysis Market is expanding as industries pr…", "url": "https://www.globenewswire.com/news-release/2026/04/07/3269302/0/en/Elemental-Analysis-Market-to-Surpass-USD-5-18-Billion-by-2035-Driven-by-Rising-Demand-for-Precise-Material-Characterization-SNS-Insider.html", "date": "2026-04-07", "published_at": "2026-04-07T13:30:00Z", "sentiment": { "label": "positive", "score": 0.052, "confidence": 0.05 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Dermatomyositis Global Clinical Trials Market Review Report 2026: Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End Point Status", "description": "The clinical trial report highlights opportunities in Dermatomyositis trials by revealing key trends in trial phases, sponsor types, and regions, particularly in G7 and E7 countries. It aids strategic decision-making by identifying prime trial locations and o…", "url": "https://www.globenewswire.com/news-release/2026/04/07/3269299/28124/en/Dermatomyositis-Global-Clinical-Trials-Market-Review-Report-2026-Region-Country-G7-E7-Trial-Status-Trial-Phase-Sponsor-Type-and-End-Point-Status.html", "date": "2026-04-07", "published_at": "2026-04-07T13:28:00Z", "sentiment": { "label": "positive", "score": 0.382, "confidence": 0.38 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Human Immunodeficiency Virus (HIV) Infections (AIDS) Global Clinical Trials Market Review 2026: Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End Point Status", "description": "The report identifies key market opportunities by revealing trends in global HIV clinical trials, highlighting trial hot spots, analyzing trial phases and statuses, and showcasing prominent drugs. It aids strategic business planning and investment by illustra…", "url": "https://www.globenewswire.com/news-release/2026/04/07/3269296/28124/en/Human-Immunodeficiency-Virus-HIV-Infections-AIDS-Global-Clinical-Trials-Market-Review-2026-Region-Country-G7-E7-Trial-Status-Trial-Phase-Sponsor-Type-and-End-Point-Status.html", "date": "2026-04-07", "published_at": "2026-04-07T13:27:00Z", "sentiment": { "label": "positive", "score": 0.599, "confidence": 0.6 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Fume Hood Market Size to Reach USD 1,132 Million by 2035, Owing to Rising Laboratory Safety Regulations and Pharma Investments | Research by SNS Insider", "description": "The Fume Hood Market is growing steadily as demand increases for safe and energy-efficient lab ventilation, with the U.S. segment rising from USD 192.98 million in 2025 to USD 298.97 million by 2035. The Fume Hood Market is growing steadily as demand increase…", "url": "https://www.globenewswire.com/news-release/2026/04/07/3268832/0/en/Fume-Hood-Market-Size-to-Reach-USD-1-132-Million-by-2035-Owing-to-Rising-Laboratory-Safety-Regulations-and-Pharma-Investments-Research-by-SNS-Insider.html", "date": "2026-04-07", "published_at": "2026-04-07T06:30:00Z", "sentiment": { "label": "positive", "score": 0.153, "confidence": 0.15 } }, { "source": "news", "source_name": "BBC News", "title": "Rugby Union Weekly", "description": "Ashy, Ugo & Chris dissect the round of 16 and preview some blockbuster quarter-finals.", "url": "https://www.bbc.co.uk/sounds/play/p0nbx08d", "date": "2026-04-06", "published_at": "2026-04-06T18:34:00Z", "sentiment": { "label": "positive", "score": 0.599, "confidence": 0.6 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Global Validation, Calibration and Standardization in Life Sciences Market to Reach $3.9 Billion by 2030, Fueled by Regulatory Demands and Digital Transformation", "description": "Increasing regulatory requirements and the need for data accuracy are driving demand for validation, calibration, and standardization in life sciences....", "url": "https://www.globenewswire.com/news-release/2026/04/06/3268627/0/en/Global-Validation-Calibration-and-Standardization-in-Life-Sciences-Market-to-Reach-3-9-Billion-by-2030-Fueled-by-Regulatory-Demands-and-Digital-Transformation.html", "date": "2026-04-06", "published_at": "2026-04-06T18:00:00Z", "sentiment": { "label": "negative", "score": -0.103, "confidence": 0.1 } }, { "source": "news", "source_name": "The Irish Times", "title": "Owen Doyle: Intrusive TMO involvement cost Ospreys a famous win against Ulster", "description": "Decision by referee Anthony Woodthorpe and his TMO David Roseon completely misread the situation and it was a blot on the Challenge Cup", "url": "https://www.irishtimes.com/sport/rugby/2026/04/06/owen-doyle-intrusive-tmo-involvement-cost-ospreys-a-famous-win-against-ulster/", "date": "2026-04-06", "published_at": "2026-04-06T16:46:05Z", "sentiment": { "label": "positive", "score": 0.403, "confidence": 0.4 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Biodesix Announces AACR 2026 Posters and Presentations, Highlighting Novel Diagnostic Test Discovery & Pipeline Development", "description": "Includes novel proteomic and genomic approaches to oncology therapeutic selection, response monitoring, and Molecular Residual Disease (MRD) testing Includes novel proteomic and genomic approaches to oncology therapeutic selection, response monitoring, and Mo…", "url": "https://www.globenewswire.com/news-release/2026/04/06/3268553/0/en/Biodesix-Announces-AACR-2026-Posters-and-Presentations-Highlighting-Novel-Diagnostic-Test-Discovery-Pipeline-Development.html", "date": "2026-04-06", "published_at": "2026-04-06T15:43:00Z", "sentiment": { "label": "positive", "score": 0.71, "confidence": 0.71 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Global In Vitro Fertilization Market to Reach USD 1,650 Million by 2029 | MarketsandMarkets™", "description": "Strategic expansion opportunities emerge across Asia-Pacific as demographic shifts and technological innovation reshape reproductive healthcare investment landscape Strategic expansion opportunities emerge across Asia-Pacific as demographic shifts and technol…", "url": "https://www.globenewswire.com/news-release/2026/04/06/3268517/0/en/Global-In-Vitro-Fertilization-Market-to-Reach-USD-1-650-Million-by-2029-MarketsandMarkets.html", "date": "2026-04-06", "published_at": "2026-04-06T14:30:00Z", "sentiment": { "label": "positive", "score": 0.984, "confidence": 0.98 } }, { "source": "news", "source_name": "Plos.org", "title": "The RNA helicase eIF4A as a novel target in insect cells to combat arboviral infections", "description": "Arthropod-borne viruses cause major global health burdens, yet few vaccines or antivirals exist. Targeting host factors required for viral replication offers a promising approach. The DEAD-box RNA helicase eIF4A, a core component of the translation initiation…", "url": "https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0346047", "date": "2026-04-06", "published_at": "2026-04-06T14:00:00Z", "sentiment": { "label": "neutral", "score": -0.042, "confidence": 0.04 } }, { "source": "news", "source_name": "Plos.org", "title": "Role of the C-terminal modules of Klebsiella phage KP32 receptor-binding protein gp38 in protein and phage functionality", "description": "Author summary Phages are viruses that attack bacteria, and they are being studied as possible alternatives to antibiotics, which are losing their effectiveness. But one big question remains: how do phages know which bacteria to infect? In our work, we looked…", "url": "https://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1014106", "date": "2026-04-06", "published_at": "2026-04-06T14:00:00Z", "sentiment": { "label": "negative", "score": -0.431, "confidence": 0.43 } }, { "source": "news", "source_name": "Plos.org", "title": "Association between chronic stress and the epigenome: Exploration of psychological and biological stress", "description": "Chronic stress is a predictor of health outcomes. Epigenetic mechanisms such as DNA methylation (DNAm) have been proposed as mediators between stress and health trajectories, with evidence from animal models supporting a causal relationship between chronic st…", "url": "https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0346517", "date": "2026-04-06", "published_at": "2026-04-06T14:00:00Z", "sentiment": { "label": "negative", "score": -0.751, "confidence": 0.75 } }, { "source": "news", "source_name": "Plos.org", "title": "The non-vesicular cholesterol transporter GRAMD1C is a pan-coronavirus antiviral target", "description": "Coronaviruses remodel host membranes for replication, but the lipid transport pathways involved are poorly understood. This study identified the cholesterol transporter GRAMD1C as a host factor that promotes replication organelle formation and supports replic…", "url": "https://journals.plos.org/plosbiology/article?id=10.1371/journal.pbio.3003736", "date": "2026-04-06", "published_at": "2026-04-06T14:00:00Z", "sentiment": { "label": "positive", "score": 0.747, "confidence": 0.75 } }, { "source": "news", "source_name": "Plos.org", "title": "Host range and zoonotic potential linked to P-like fimbrial (PLF) adhesin specificity in avian pathogenic Escherichia coli", "description": "Author summary Bacteria often use hair-like structures called fimbriae to attach to host cells and begin infection. In this study, we investigated a newly identified P-like (PL) fimbrial system in an avian pathogenic Escherichia coli strain isolated from a di…", "url": "https://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1013691", "date": "2026-04-06", "published_at": "2026-04-06T14:00:00Z", "sentiment": { "label": "negative", "score": -0.361, "confidence": 0.36 } }, { "source": "news", "source_name": "Plos.org", "title": "The m6Am methyltransferase PCIF1 promotes osteogenic differentiation of mesenchymal stem cells through stabilization of Wnt-related transcripts", "description": "Emerging research has highlighted the regulatory roles of m6A RNA modifications on bone homeostasis, but the function of m6Am modifications are not as well understood. This study shows that the PCIF1 m6Am methyltransferase supports bone mass maintenance by st…", "url": "https://journals.plos.org/plosbiology/article?id=10.1371/journal.pbio.3003739", "date": "2026-04-06", "published_at": "2026-04-06T14:00:00Z", "sentiment": { "label": "positive", "score": 0.408, "confidence": 0.41 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Membrane Filters Market Size to Surpass USD 30.21 Billion by 2035 | SNS Insider", "description": "The Membrane Filters Market is expanding as demand grows across water treatment and life sciences, with the U.S. segment increasing from USD 4.61 billion in 2025 to USD 11.03 billion by 2035 amid regulatory and industrial growth. The Membrane Filters Market i…", "url": "https://www.globenewswire.com/news-release/2026/04/06/3268318/0/en/Membrane-Filters-Market-Size-to-Surpass-USD-30-21-Billion-by-2035-SNS-Insider.html", "date": "2026-04-06", "published_at": "2026-04-06T10:30:00Z", "sentiment": { "label": "positive", "score": 0.273, "confidence": 0.27 } }, { "source": "news", "source_name": "Nature.com", "title": "Charged molecular glue discovery enabled by targeted degron display", "description": "The study reveals a ‘chemocentric’ strategy for identifying charged molecular glue degraders, through discovering a bromodomain-binding molecular glue degrader prodrug that is metabolically activated in cells to recruit the YPEL5-CTLH E3 ligase.", "url": "https://www.nature.com/articles/s41589-026-02182-5", "date": "2026-04-06", "published_at": "2026-04-06T00:00:00Z", "sentiment": { "label": "negative", "score": -0.823, "confidence": 0.82 } }, { "source": "news", "source_name": "Yahoo Entertainment", "title": "Dragons' shock win keeps Wales in Europe after TMO woe", "description": "Dragons will hunt another victory in the quarter-finals of the Challenge Cup as Cardiff and Ospreys reflect on controversial exits.", "url": "https://consent.yahoo.com/v2/collectConsent?sessionId=1_cc-session_b035e4ea-5d6f-4741-b666-d7a0756b26fe", "date": "2026-04-05", "published_at": "2026-04-05T20:02:32Z", "sentiment": { "label": "negative", "score": -0.273, "confidence": 0.27 } }, { "source": "news", "source_name": "BBC News", "title": "Dragons' shock win keeps Wales in Europe after TMO woe", "description": "Dragons will hunt another victory in the quarter-finals of the Challenge Cup as Cardiff and Ospreys reflect on controversial exits.", "url": "https://www.bbc.com/sport/rugby-union/articles/cy41rl94324o", "date": "2026-04-05", "published_at": "2026-04-05T20:02:26Z", "sentiment": { "label": "negative", "score": -0.273, "confidence": 0.27 } }, { "source": "news", "source_name": "RTE", "title": "Leinster through to quarters after wild win v Edinburgh", "description": "Leinster set up an Investec Champions Cup quarter-final against Sale Sharks next Saturday, but Leo Cullen's side were given a minor scare by Edinburgh in a wild 12-try affair at Aviva Stadium.", "url": "https://www.rte.ie/sport/rugby/2026/0405/1566794-leinster-through-to-quarters-after-wild-win-v-edinburgh/", "date": "2026-04-05", "published_at": "2026-04-05T18:23:59Z", "sentiment": { "label": "negative", "score": -0.178, "confidence": 0.18 } }, { "source": "news", "source_name": "BBC News", "title": "Leinster beat Edinburgh in Champions Cup thriller", "description": "Leinster turn on the style in the second half to beat Edinburgh 49-31 in a chaotic Champions Cup last-16 game at the Aviva Stadium.", "url": "https://www.bbc.com/sport/rugby-union/articles/cly7rxnv3nwo?xtor=AL-72-%5Bpartner%5D-%5Byahoo.north.america%5D-%5Bheadline%5D-%5Bsport%5D-%5Bbizdev%5D-%5Bisapi%5D", "date": "2026-04-05", "published_at": "2026-04-05T18:22:29Z", "sentiment": { "label": "positive", "score": 0.612, "confidence": 0.61 } }, { "source": "news", "source_name": "BBC News", "title": "Leinster beat Edinburgh in Champions Cup thriller", "description": "Leinster turn on the style in the second half to beat Edinburgh 49-31 in a chaotic Champions Cup last-16 game at the Aviva Stadium.", "url": "https://www.bbc.com/sport/rugby-union/articles/cly7rxnv3nwo", "date": "2026-04-05", "published_at": "2026-04-05T18:22:23Z", "sentiment": { "label": "positive", "score": 0.612, "confidence": 0.61 } }, { "source": "news", "source_name": "BBC News", "title": "Wakefield beat Castleford to keep pace with leaders", "description": "Wakefield Trinity keep pace with the top few sides in the Super League table following a comfortable win at Castleford Tigers.", "url": "https://www.bbc.com/sport/rugby-league/articles/c4gj2ekzrp1o?xtor=AL-72-%5Bpartner%5D-%5Byahoo.north.america%5D-%5Bheadline%5D-%5Bsport%5D-%5Bbizdev%5D-%5Bisapi%5D", "date": "2026-04-05", "published_at": "2026-04-05T16:10:47Z", "sentiment": { "label": "positive", "score": 0.915, "confidence": 0.92 } }, { "source": "news", "source_name": "BBC News", "title": "Murphy praises Ulster 'grit' in win over Ospreys", "description": "Ulster head coach Richie Murphy praises his side's resilience in their 28-24 win over Ospreys in the European Challenge Cup.", "url": "https://www.bbc.com/sport/rugby-union/articles/czjwm1e0x1xo?xtor=AL-72-%5Bpartner%5D-%5Byahoo.north.america%5D-%5Bheadline%5D-%5Bsport%5D-%5Bbizdev%5D-%5Bisapi%5D", "date": "2026-04-05", "published_at": "2026-04-05T08:40:41Z", "sentiment": { "label": "positive", "score": 0.94, "confidence": 0.94 } }, { "source": "news", "source_name": "BBC News", "title": "Murphy praises Ulster 'grit' in win over Ospreys", "description": "Ulster head coach Richie Murphy praises his side's resilience in their 28-24 win over Ospreys in the European Challenge Cup.", "url": "https://www.bbc.com/sport/rugby-union/articles/czjwm1e0x1xo", "date": "2026-04-05", "published_at": "2026-04-05T08:40:36Z", "sentiment": { "label": "positive", "score": 0.94, "confidence": 0.94 } }, { "source": "news", "source_name": "BBC News", "title": "Sale hold off Quins comeback to reach last eight", "description": "Sale Sharks hold off a second-half comeback from Harlequins to progress to the Champions Cup quarter-finals.", "url": "https://www.bbc.com/sport/rugby-union/articles/clyrvd272y2o?xtor=AL-72-%5Bpartner%5D-%5Byahoo.north.america%5D-%5Bheadline%5D-%5Bsport%5D-%5Bbizdev%5D-%5Bisapi%5D", "date": "2026-04-04", "published_at": "2026-04-04T21:39:20Z", "sentiment": { "label": "positive", "score": 0.743, "confidence": 0.74 } }, { "source": "news", "source_name": "The Irish Times", "title": "Ulster ride their luck to beat Ospreys and set up La Rochelle quarter-final in Belfast", "description": "Ospreys will feel aggrieved at having Kieran Hardy’s late try ruled out for a forward pass", "url": "https://www.irishtimes.com/sport/rugby/2026/04/04/ulster-ride-their-luck-to-beat-ospreys-and-set-up-la-rochelle-quarter-final-in-belfast/", "date": "2026-04-04", "published_at": "2026-04-04T21:26:36Z", "sentiment": { "label": "positive", "score": 0.459, "confidence": 0.46 } }, { "source": "news", "source_name": "BBC News", "title": "Ulster beat Ospreys to progress in Challenge Cup", "description": "An efficient Ulster side see off Ospreys 28-24 in an entertaining contest at the Affidea Stadium to reach the Challenge Cup quarter-finals.", "url": "https://www.bbc.com/sport/rugby-union/articles/c1mkpxy4mjgo?xtor=AL-72-%5Bpartner%5D-%5Byahoo.north.america%5D-%5Bheadline%5D-%5Bsport%5D-%5Bbizdev%5D-%5Bisapi%5D", "date": "2026-04-04", "published_at": "2026-04-04T21:09:53Z", "sentiment": { "label": "positive", "score": 0.848, "confidence": 0.85 } }, { "source": "news", "source_name": "BBC News", "title": "Ulster beat Ospreys to progress in Challenge Cup", "description": "An efficient Ulster side see off Ospreys 28-24 in an entertaining contest at the Affidea Stadium to reach the Challenge Cup quarter-finals.", "url": "https://www.bbc.com/sport/rugby-union/articles/c1mkpxy4mjgo", "date": "2026-04-04", "published_at": "2026-04-04T21:09:47Z", "sentiment": { "label": "positive", "score": 0.848, "confidence": 0.85 } }, { "source": "news", "source_name": "BBC News", "title": "Bath hold off brave Saracens to reach last eight", "description": "Bath hold off a brave effort from out-of-form Saracens to book their place in the Champions Cup quarter-finals.", "url": "https://www.bbc.com/sport/rugby-union/articles/c0q9lll4e8do?xtor=AL-72-%5Bpartner%5D-%5Byahoo.north.america%5D-%5Bheadline%5D-%5Bsport%5D-%5Bbizdev%5D-%5Bisapi%5D", "date": "2026-04-04", "published_at": "2026-04-04T16:09:07Z", "sentiment": { "label": "positive", "score": 0.883, "confidence": 0.88 } }, { "source": "news", "source_name": "BBC News", "title": "Saints pass stern Castres test to reach last eight", "description": "Northampton are given a stern examination of their Champions Cup credentials by impressive Castres but win an engrossing contest to reach the quarter-finals.", "url": "https://www.bbc.com/sport/rugby-union/articles/c070d4vk8g9o?xtor=AL-72-%5Bpartner%5D-%5Byahoo.north.america%5D-%5Bheadline%5D-%5Bsport%5D-%5Bbizdev%5D-%5Bisapi%5D", "date": "2026-04-03", "published_at": "2026-04-03T21:42:14Z", "sentiment": { "label": "positive", "score": 0.867, "confidence": 0.87 } }, { "source": "news", "source_name": "BBC News", "title": "Champions Cup last 16 team news and line-ups", "description": "Champions Cup team news and line-ups for this weekend's last-16 matches - all in one place.", "url": "https://www.bbc.com/sport/rugby-union/articles/c4g8kvezy19o?xtor=AL-72-%5Bpartner%5D-%5Byahoo.north.america%5D-%5Bheadline%5D-%5Bsport%5D-%5Bbizdev%5D-%5Bisapi%5D", "date": "2026-04-03", "published_at": "2026-04-03T17:28:04Z", "sentiment": { "label": "positive", "score": 0.778, "confidence": 0.78 } }, { "source": "news", "source_name": "Business Insider", "title": "Inside the rise of Trump's favorite online brawler", "description": "Alex Bruesewitz has gone from a MAGA influencer to Donald Trump's celebrity ambassador, ushering a stream of stars to the president's side.", "url": "https://www.businessinsider.com/alex-bruesewitz-donald-trump-maga-influencer-nicki-minaj-trump-accounts-2026-4", "date": "2026-04-03", "published_at": "2026-04-03T16:24:08Z", "sentiment": { "label": "positive", "score": 0.459, "confidence": 0.46 } }, { "source": "news", "source_name": "Plos.org", "title": "Identification of Leishmania spp. and Trypanosoma cruzi in bats captured in El Paso County, Texas", "description": "Author summary Leishmaniasis and Chagas disease affect millions of people in the Americas and other parts of the world. These diseases are mainly transmitted by insect vectors, the sand fly for Leishmania, and the kissing bug for Trypanosoma cruzi. Wild and d…", "url": "https://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0014169", "date": "2026-04-03", "published_at": "2026-04-03T14:00:00Z", "sentiment": { "label": "positive", "score": 0.572, "confidence": 0.57 } }, { "source": "news", "source_name": "Plos.org", "title": "FOXO1 transcription factor modulates airway epithelial responses to viral infection", "description": "The airway epithelium serves as the initial barrier of defence in the respiratory system, guarding against microbial, chemical, and environmental threats introduced through inhaled air. Pattern recognition receptors within the airway epithelium facilitate the…", "url": "https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0345169", "date": "2026-04-03", "published_at": "2026-04-03T14:00:00Z", "sentiment": { "label": "negative", "score": -0.44, "confidence": 0.44 } }, { "source": "news", "source_name": "Plos.org", "title": "Discovery of a potent anti-Zika virus benzamide series targeting the viral protein NS4B", "description": "Author summary Since its pandemic spread in 2015–2016, Zika virus infection remains a significant public health threat worldwide. The virus can cause severe brain damage in developing babies and serious neurological complications like Guillain-Barré syndrome …", "url": "https://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1013609", "date": "2026-04-03", "published_at": "2026-04-03T14:00:00Z", "sentiment": { "label": "negative", "score": -0.735, "confidence": 0.74 } }, { "source": "news", "source_name": "Plos.org", "title": "Anti-cancer effect of a novel photodynamic therapy using glucose-linked chlorin e6 conjugated trastuzumab for HER2-positive gastrointestinal cancers", "description": "Photodynamic therapy (PDT) is an anti-cancer therapy that employs a photosensitizer (PS) and an optimal wavelength of light, causing a photochemical reaction that releases reactive oxygen species, thereby inducing cancer cell death via oxidative stress. Becau…", "url": "https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0346567", "date": "2026-04-03", "published_at": "2026-04-03T14:00:00Z", "sentiment": { "label": "negative", "score": -0.807, "confidence": 0.81 } }, { "source": "news", "source_name": "Plos.org", "title": "Benthic bacteria communities of coral reefs are shaped by sediment properties rather than coral trophic state", "description": "Understanding how different reef components contribute to ecosystem stability and function is crucial for assessing the health of reefs. Reef sediments and their associated bacteria are essential for reef productivity and stability, but are often overlooked i…", "url": "https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0346135", "date": "2026-04-03", "published_at": "2026-04-03T14:00:00Z", "sentiment": { "label": "neutral", "score": -0.039, "confidence": 0.04 } }, { "source": "news", "source_name": "Plos.org", "title": "Lactobacillus casei culture supernatant ameliorates acute alcohol-induced liver injury by inhibiting cellular stress and promoting intestinal integrity in mice", "description": "Alcohol-associated liver disease (ALD) is a common liver disease worldwide. Probiotics prevent alcohol-induced liver injury and improve intestinal integrity. However, the precise mechanisms behind these effects are not fully understood. In the present study, …", "url": "https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0344960", "date": "2026-04-03", "published_at": "2026-04-03T14:00:00Z", "sentiment": { "label": "positive", "score": 0.226, "confidence": 0.23 } }, { "source": "news", "source_name": "BBC News", "title": "Mann back for injury-hit Cardiff at Benetton", "description": "Wales flanker Alex Mann returns but Cardiff are down to bare bones for Challenge Cup last-16 tie at Benetton.", "url": "https://www.bbc.com/sport/rugby-union/articles/cvg38e9224yo?xtor=AL-72-%5Bpartner%5D-%5Byahoo.north.america%5D-%5Bheadline%5D-%5Bsport%5D-%5Bbizdev%5D-%5Bisapi%5D", "date": "2026-04-03", "published_at": "2026-04-03T11:11:46Z", "sentiment": { "label": "positive", "score": 0.115, "confidence": 0.12 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Molecular Diagnostics Market Size is Expected to Reach USD 43.50 Billion by 2035 Owing to the Surging Demand for Accurate and Early Disease Detection Globally | SNS Insider", "description": "Molecular diagnostics market to grow from $18.26 Bn to $43.50 Bn by 2035, driven by PCR, NGS, and demand for early, precise diagnosis....", "url": "https://www.globenewswire.com/news-release/2026/04/03/3267957/0/en/Molecular-Diagnostics-Market-Size-is-Expected-to-Reach-USD-43-50-Billion-by-2035-Owing-to-the-Surging-Demand-for-Accurate-and-Early-Disease-Detection-Globally-SNS-Insider.html", "date": "2026-04-03", "published_at": "2026-04-03T09:00:00Z", "sentiment": { "label": "negative", "score": -0.226, "confidence": 0.23 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Drug Screening Market Trends 2026–2031: Chromatography and Mass Spectrometry Held a 44.77% Share in 2025 Amid Growing Demand for Advanced Testing, Reports Mordor Intelligence", "description": "Global drug screening market to grow at a 16.16% CAGR to USD 20.86B by 2031, driven by demand for rapid testing and advanced analytical technologies....", "url": "https://www.globenewswire.com/news-release/2026/04/03/3267950/0/en/Drug-Screening-Market-Trends-2026-2031-Chromatography-and-Mass-Spectrometry-Held-a-44-77-Share-in-2025-Amid-Growing-Demand-for-Advanced-Testing-Reports-Mordor-Intelligence.html", "date": "2026-04-03", "published_at": "2026-04-03T07:15:00Z", "sentiment": { "label": "positive", "score": 0.791, "confidence": 0.79 } }, { "source": "news", "source_name": "Boston Herald", "title": "Takeda Pharmaceuticals to lay off 247 employees at Cambridge location", "description": "Takeda Pharmaceuticals – Massachusetts’ largest biopharma employer – is laying off 247 employees as residents and businesses continue to flee the state due to costly state taxes and policies.", "url": "https://www.bostonherald.com/2026/04/02/takeda-pharmaceuticals-to-lay-off-247-employees-at-cambridge-location/", "date": "2026-04-02", "published_at": "2026-04-02T20:26:32Z", "sentiment": { "label": "negative", "score": -0.103, "confidence": 0.1 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Assisted Reproductive Technology Market Set to Reach $6.02 Billion by 2030 | MarketsandMarkets™", "description": "Increasing demand for IVF, expanding fertility clinics, and innovation in reproductive technologies drive sustained growth at a 7.0% CAGR Increasing demand for IVF, expanding fertility clinics, and innovation in reproductive technologies drive sustained growt…", "url": "https://www.globenewswire.com/news-release/2026/04/02/3267511/0/en/Assisted-Reproductive-Technology-Market-Set-to-Reach-6-02-Billion-by-2030-MarketsandMarkets.html", "date": "2026-04-02", "published_at": "2026-04-02T14:30:00Z", "sentiment": { "label": "positive", "score": 0.91, "confidence": 0.91 } }, { "source": "news", "source_name": "Plos.org", "title": "Specificity and recognition of the ADP-ribosyl-ubiquitin modification in the DNA damage response", "description": "Recent studies have shown that ADP-ribose modifications can be further modified by ubiquitin (ADPr-Ub), but there are still major gaps in our knowledge around this modification and its role in the DNA damage response. This study biochemically characterises th…", "url": "https://journals.plos.org/plosbiology/article?id=10.1371/journal.pbio.3003747", "date": "2026-04-02", "published_at": "2026-04-02T14:00:00Z", "sentiment": { "label": "negative", "score": -0.751, "confidence": 0.75 } }, { "source": "news", "source_name": "Plos.org", "title": "Mitochondrial NAD kinase Pos5 is required for CoQ biosynthesis in yeasts", "description": "Coenzyme Q (CoQ) is an essential component of the electron transport chain, and ten genes involved in CoQ biosynthesis have been identified in Schizosaccharomyces pombe. To gain further insight into CoQ biosynthesis, we screened the Bioneer gene-deletion libr…", "url": "https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0346295", "date": "2026-04-02", "published_at": "2026-04-02T14:00:00Z", "sentiment": { "label": "positive", "score": 0.527, "confidence": 0.53 } }, { "source": "news", "source_name": "Plos.org", "title": "Primary cilia in osteoblasts and osteocytes are required for skeletal development and mechano-adaptation", "description": "Primary cilia play a crucial role in the development and mechanosensation of various tissue types, including bone. In this study, we investigated their role in bone growth and adaptation by targeting two cilia specific genes, IFT88 and MKS5. Conditional knock…", "url": "https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0346015", "date": "2026-04-02", "published_at": "2026-04-02T14:00:00Z", "sentiment": { "label": "positive", "score": 0.612, "confidence": 0.61 } }, { "source": "news", "source_name": "Plos.org", "title": "Defining the impact of Getah virus envelope protein glycosylation site mutations on viral replication, host adaptation, virulence, and immune evasion", "description": "Author summary Getah virus (GETV), an emerging mosquito-borne zoonotic alphavirus, causes significant outbreaks in animals. Epidemic strains possess a distinct N-glycosylation site (E2-N262) absent in historical lineages. The functional roles of this and cons…", "url": "https://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1014126", "date": "2026-04-02", "published_at": "2026-04-02T14:00:00Z", "sentiment": { "label": "positive", "score": 0.202, "confidence": 0.2 } }, { "source": "news", "source_name": "BBC News", "title": "Belleau starts at fly-half as Saints face Castres", "description": "Anthony Belleau starts at fly-half as Northampton Saints make six changes for their Champions Cup last-16 tie against Castres at Franklin's Gardens on Friday...", "url": "https://www.bbc.com/sport/rugby-union/articles/c80mp520d47o?xtor=AL-72-%5Bpartner%5D-%5Byahoo.north.america%5D-%5Bheadline%5D-%5Bsport%5D-%5Bbizdev%5D-%5Bisapi%5D", "date": "2026-04-02", "published_at": "2026-04-02T13:30:05Z", "sentiment": { "label": "positive", "score": 0.527, "confidence": 0.53 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "[Latest] Global Environmental Mass Spectrometry Market Size/Share Worth USD 6.47 Billion by 2035 at a 7.6% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)", "description": "[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Environmental Mass Spectrometry Market size & share revenue was valued at approximately USD 2.84 Billion in 2025 and is expected…", "url": "https://www.globenewswire.com/news-release/2026/04/02/3267246/0/en/Latest-Global-Environmental-Mass-Spectrometry-Market-Size-Share-Worth-USD-6-47-Billion-by-2035-at-a-7-6-CAGR-Custom-Market-Insights-Analysis-Outlook-Leaders-Report-Trends-Forecast-.html", "date": "2026-04-02", "published_at": "2026-04-02T11:30:00Z", "sentiment": { "label": "positive", "score": 0.859, "confidence": 0.86 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Chemoinformatics Market Size is Poised to be USD 19.12 Billion by 2035 Due to the Integration of AI and ML Globally | SNS Insider", "description": "Chemoinformatics market to reach $ 19.12 Bn by 2035 at 15.55% CAGR, driven by AI-led drug discovery, molecular modeling, and rising pharma R&D investments.", "url": "https://www.globenewswire.com/news-release/2026/04/02/3267166/0/en/Chemoinformatics-Market-Size-is-Poised-to-be-USD-19-12-Billion-by-2035-Due-to-the-Integration-of-AI-and-ML-Globally-SNS-Insider.html", "date": "2026-04-02", "published_at": "2026-04-02T09:30:00Z", "sentiment": { "label": "positive", "score": 0.273, "confidence": 0.27 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Antimicrobial Resistance Surveillance Market Set to Reach USD 11.17 Billion by 2035 – SNS Insider", "description": "Rising prevalence of drug-resistant infections and government-led monitoring initiatives drive a steady 5.47% CAGR through 2035. Rising prevalence of drug-resistant infections and government-led monitoring initiatives drive a steady 5.47% CAGR through 2035.", "url": "https://www.globenewswire.com/news-release/2026/04/02/3267148/0/en/Antimicrobial-Resistance-Surveillance-Market-Set-to-Reach-USD-11-17-Billion-by-2035-SNS-Insider.html", "date": "2026-04-02", "published_at": "2026-04-02T08:30:00Z", "sentiment": { "label": "neutral", "score": 0.026, "confidence": 0.03 } }, { "source": "news", "source_name": "Plos.org", "title": "Role of donor nerves in supercharge end-to-side nerve transfer: A rat model study of varying injury severity", "description": "Supercharge end-to-side (SETS) nerve transfer enhances motor recovery in proximal nerve injuries by providing early reinnervation. However, the optimal indications and mechanisms remain unclear. This study examined the role of donor nerves using rat models of…", "url": "https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0346252", "date": "2026-04-01", "published_at": "2026-04-01T14:00:00Z", "sentiment": { "label": "negative", "score": -0.477, "confidence": 0.48 } }, { "source": "news", "source_name": "Plos.org", "title": "Saliva and plasma metabolome analysis during the five days before foaling in the mare", "description": "Saliva is a relevant biofluid for real-time welfare-friendly monitoring of systemic events in animals, because some bioanalytes have a systemic origin and its collection is painless, stress-free and non-invasive. Our aim was to analyze the metabolome of equin…", "url": "https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0344530", "date": "2026-04-01", "published_at": "2026-04-01T14:00:00Z", "sentiment": { "label": "positive", "score": 0.296, "confidence": 0.3 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Protein Chip Market Size is Expected to Reach USD 4.79 Billion by 2035 Owing to the Rapid Adoption of Mass-screening Proteomics Technologies Globally | SNS Insider", "description": "Protein chip market grows to USD 4.79 Billion by 2035 at 6.89% CAGR, driven by proteomics research, and rising clinical diagnostics adoption....", "url": "https://www.globenewswire.com/news-release/2026/04/01/3266380/0/en/Protein-Chip-Market-Size-is-Expected-to-Reach-USD-4-79-Billion-by-2035-Owing-to-the-Rapid-Adoption-of-Mass-screening-Proteomics-Technologies-Globally-SNS-Insider.html", "date": "2026-04-01", "published_at": "2026-04-01T09:30:00Z", "sentiment": { "label": "neutral", "score": 0.026, "confidence": 0.03 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "In Vitro Fertilization (IVF) Market Projected to Hit USD 44.68 Billion by 2035; Rising Infertility Rates Fueling 7.47% CAGR – SNS Insider", "description": "Advancements in assisted reproductive technologies, and increasing demand for personalized fertility treatments drive the global IVF market from a USD 21.74 billion valuation in 2025 to nearly double by 2035. Advancements in assisted reproductive technologies…", "url": "https://www.globenewswire.com/news-release/2026/04/01/3266351/0/en/In-Vitro-Fertilization-IVF-Market-Projected-to-Hit-USD-44-68-Billion-by-2035-Rising-Infertility-Rates-Fueling-7-47-CAGR-SNS-Insider.html", "date": "2026-04-01", "published_at": "2026-04-01T08:30:00Z", "sentiment": { "label": "negative", "score": -0.128, "confidence": 0.13 } }, { "source": "news", "source_name": "Nature.com", "title": "DNA damage burden causes selective CUX2 neuron loss in neuroinflammation", "description": "DNA damage burden and inadequate repair in CUX2+ cortical layer 2/3 excitatory neurons contributes to selective vulnerability in neuroinflammatory injury.", "url": "https://www.nature.com/articles/s41586-026-10310-3", "date": "2026-04-01", "published_at": "2026-04-01T00:00:00Z", "sentiment": { "label": "negative", "score": -1.0, "confidence": 1.0 } }, { "source": "news", "source_name": "Nature.com", "title": "A µ-opioid receptor superagonist analgesic with minimal adverse effects", "description": "N-desethyl-fluornitrazene is a µ-opioid receptor agonist derived from nitazenes that has supramaximal intrinsic efficacy that produces analgesia with minimal adverse effects in rodent models.", "url": "https://www.nature.com/articles/s41586-026-10299-9", "date": "2026-04-01", "published_at": "2026-04-01T00:00:00Z", "sentiment": { "label": "negative", "score": -0.612, "confidence": 0.61 } }, { "source": "news", "source_name": "Nature.com", "title": "Mosaic gastruloids reveal a temporal restriction for developmental cell competition", "description": "Frenster et al. utilize mosaic mouse gastruloids as a model of cell fitness and competition, identifying a temporal window between primed pluripotency and early gastrulation during which cell competition occurs in mammalian embryogenesis.", "url": "https://www.nature.com/articles/s41556-026-01923-x", "date": "2026-04-01", "published_at": "2026-04-01T00:00:00Z", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "news", "source_name": "Nature.com", "title": "AhR inhibition promotes axon regeneration via a stress–growth switch", "description": "AhR functions as a neuronal brake on axon regeneration, integrating environmental sensing, protein homeostasis and metabolic signalling to control the balance between stress adaptation and axonal repair.", "url": "https://www.nature.com/articles/s41586-026-10295-z", "date": "2026-04-01", "published_at": "2026-04-01T00:00:00Z", "sentiment": { "label": "negative", "score": -0.44, "confidence": 0.44 } }, { "source": "news", "source_name": "Nature.com", "title": "Deconstruction of a spino-brain–spinal cord circuit that drives chronic pain", "description": "In mice, a circuit between the spinal cord and various regions of the brain, centring on spinal-cord-projecting neurons in the rostral ventromedial medulla, has a key role in driving chronic pain.", "url": "https://www.nature.com/articles/s41586-026-10296-y", "date": "2026-04-01", "published_at": "2026-04-01T00:00:00Z", "sentiment": { "label": "negative", "score": -0.765, "confidence": 0.77 } }, { "source": "news", "source_name": "GlobeNewswire", "title": "Wilms Tumor Protein Market Outlook 2026-2030 and 2035 Shows 6.9% CAGR as Rising Investment in Oncology Research Accelerates Industry Growth", "description": "Dublin, March 31, 2026 (GLOBE NEWSWIRE) -- The \"Wilms Tumor Protein Market Report 2026\" has been added to ResearchAndMarkets.com's offering. The report provides a comprehensive analysis, covering market statistics, regional shares, competitor data, market seg…", "url": "https://www.globenewswire.com/news-release/2026/03/31/3265766/28124/en/Wilms-Tumor-Protein-Market-Outlook-2026-2030-and-2035-Shows-6-9-CAGR-as-Rising-Investment-in-Oncology-Research-Accelerates-Industry-Growth.html", "date": "2026-03-31", "published_at": "2026-03-31T15:07:00Z", "sentiment": { "label": "positive", "score": 0.153, "confidence": 0.15 } }, { "source": "news", "source_name": "Plos.org", "title": "GSK3β as a potential regulator in AML: A pan-cancer multi-omics analysis", "description": "The distinct roles of GSK3 isoforms (GSK3α/β) in tumorigenesis and immune modulation remain poorly characterized across malignancies. We integrated multi-omics data from TCGA, GTEx, and single-cell RNA-seq to analyze GSK3α/β expression patterns in 31 cancers.…", "url": "https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0344994", "date": "2026-03-31", "published_at": "2026-03-31T14:00:00Z", "sentiment": { "label": "positive", "score": 0.809, "confidence": 0.81 } }, { "source": "news", "source_name": "Plos.org", "title": "Characterization of EOP-1 reveals cell autonomous oscillations preceding somatic cell fusion in Neurospora crassa", "description": "Author summary In many filamentous fungi, colony establishment and growth involves somatic cell fusion. Genetically identical germinating spores merge to form a connected network that develops into the mycelium. Within this colony, additional fusions between …", "url": "https://journals.plos.org/plosgenetics/article?id=10.1371/journal.pgen.1012087", "date": "2026-03-31", "published_at": "2026-03-31T14:00:00Z", "sentiment": { "label": "positive", "score": 0.382, "confidence": 0.38 } } ] } }